Exact Mass: 334.2144

Exact Mass Matches: 334.2144

Found 500 metabolites which its exact mass value is equals to given mass value 334.2144, within given mass tolerance error 8.0E-6 dalton. Try search metabolite list with more accurate mass tolerance error 1.6E-6 dalton.

Dihexyl phthalate

1,2-dihexyl benzene-1,2-dicarboxylate

C20H30O4 (334.2144)


CONFIDENCE standard compound; INTERNAL_ID 1314; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10876; ORIGINAL_PRECURSOR_SCAN_NO 10875 CONFIDENCE standard compound; INTERNAL_ID 1314; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10893; ORIGINAL_PRECURSOR_SCAN_NO 10892 CONFIDENCE standard compound; INTERNAL_ID 1314; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10920; ORIGINAL_PRECURSOR_SCAN_NO 10918 CONFIDENCE standard compound; INTERNAL_ID 1314; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10916; ORIGINAL_PRECURSOR_SCAN_NO 10915 CONFIDENCE standard compound; INTERNAL_ID 1314; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10914; ORIGINAL_PRECURSOR_SCAN_NO 10912 CONFIDENCE standard compound; INTERNAL_ID 1314; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10870; ORIGINAL_PRECURSOR_SCAN_NO 10868

   

Prostaglandin J2

(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoic acid

C20H30O4 (334.2144)


Prostaglandin J2 (PGJ2) is an endogenous product of inflammation in humans. It induces neuronal death and the accumulation of ubiquitinated proteins into distinct aggregates. It may play a role in neurodegenerative disorders inducing a chain of events that culminates in neuronal cell death. An altered expression of enzymes in PGJ2 synthesis may represent a novel pathogenic mechanism in human obesity. The peroxisome proliferator-activated receptor gamma (PPARγ) has a fundamental role in glucose homeostasis and adipocyte differentiation. Besides linoleate, linolenate and arachidonate, the most notable PPAR ligand is 15-deoxy-delta12-14-prostaglandin J2, a natural derivative of prostaglandin D2 and PGJ2. It is therefore plausible that the production of 15d-PGJ2 within adipose tissue may act as an endogenous mediator of adipocyte differentiation. PGJ2 disrupts the cytoskeleton in neuronal cells. This cyclopentenone prostaglandin triggered endoplasmic reticulum (ER) collapse and the redistribution of ER proteins, such as calnexin and catechol-O-methyltransferase, into a large centrosomal aggregate containing ubiquitinated proteins and alpha-synuclein. The PGJ2-dependent cytoskeletal rearrangement paralleled the development of the large centrosomal aggregate. Supporting a mechanism by which, upon PGJ2 treatment, cytoskeleton/ER collapse coincides with the relocation of ER proteins, other potentially neighboring proteins, and ubiquitinated proteins into centrosomal aggregates. Development of these large perinuclear aggregates is associated with disruption of the microtubule/ER network. This aberrant protein deposition, triggered by a product of inflammation, may be common to other compounds that disrupt microtubules and induce protein aggregation, such as MPP+ and rotenone, found to be associated with neurodegeneration. Many neurodegenerative disorders, such as Parkinson disease, exhibit inclusion bodies containing ubiquitinated proteins. Concentrations of PGJ2 in biofluids have not been established, since this prostaglandin is further metabolized into delta12-PGJ2, and 15-deoxy-delta12,14-PGJ2. (PMID: 16737963, 16842938, 16774923)Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. Prostaglandin J2 (PGJ2) is an endogenous product of inflammation in humans. It induces neuronal death and the accumulation of ubiquitinated proteins into distinct aggregates. It may play a role in neurodegenerative disorders inducing a chain of events that culminates in neuronal cell death. An altered expression of enzymes in PGJ2 synthesis may represent a novel pathogenic mechanism in human obesity. The peroxisome proliferator-activated receptor gamma (PPARγ) has a fundamental role in glucose homeostasis and adipocyte differentiation. Besides linoleate, linolenate and arachidonate, the most notable PPAR ligand is 15-deoxy-delta12-14-prostaglandin J2, a natural derivative of prostaglandin D2 and PGJ2. It is therefore plausible that the production of 15d-PGJ2 within adipose tissue may act as an endogenous mediator of adipocyte differentiation. PGJ2 disrupts the cytoskeleton in neuronal cells. This cyclopentenone prostaglandin triggered endoplasmic reticulum (ER) collapse and the redistribution of ER proteins, such as calnexin and catechol-O-methyltransferase, into a large centrosomal aggregate containing ubiquitinated proteins and alpha-synuclein. The PGJ2-dependent cytoskeletal rearrangement paralleled the development of the large centrosomal aggregate. Supporting a mechanism by which, upon PGJ2 treatment, cytoskeleton/ER collapse coincides with the relocation of ER proteins, other potentially neighboring proteins, and ubiquitinated proteins into centrosomal aggregates. Development of these large perinuclear aggregates is associated with disruption of the microtubule/ER network. This aberrant protein deposition, triggered by a product of inflammation, may be common to other compounds that disrupt microtubules and induce protein aggregation, such as MPP+ and rotenone, found to be associated with neurodegeneration. Many neurodegenerative disorders, such as Parkinson disease, exhibit inclusion bodies containing ubiquitinated proteins. Concentrations of PGJ2 in biofluids have not been established, since this prostaglandin is further metabolized into delta12-PGJ2, and 15-deoxy-delta12,14-PGJ2. (PMID: 16737963, 16842938, 16774923) D000970 - Antineoplastic Agents

   

Prostaglandin B2

(5Z)-7-{2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopent-1-en-1-yl}hept-5-enoic acid

C20H30O4 (334.2144)


Prostaglandin B2 (PGB2) is a prostanoid. Prostanoids is a term that collectively describes prostaglandins, prostacyclines and thromboxanes. Prostanoids are a subclass of the lipid mediator group known as eicosanoids. They derive from C-20 polyunsaturated fatty acids, mainly dihomo-gamma-linoleic (20:3n-6), arachidonic (20:4n-6), and eicosapentaenoic (20:5n-3) acids, through the action of cyclooxygenases-1 and -2 (COX-1 and COX-2). The reaction product of COX is the unstable endoperoxide prostaglandin H (PGH) that is further transformed into the individual prostanoids by a series of specific prostanoid synthases. Prostanoids are local-acting mediators formed and inactivated within the same or neighbouring cells prior to their release into circulation as inactive metabolites (15-keto- and 13,14-dihydroketo metabolites). Non-enzymatic peroxidation of arachidonic acid and other fatty acids in vivo can result in prostaglandin-like substances isomeric to the COX-derived prostaglandins that are termed isoprostanes. Prostanoids take part in many physiological and pathophysiological processes in practically every organ, tissue and cell, including the vascular, renal, gastrointestinal and reproductive systems. Their activities are mediated through prostanoid-specific receptors and intracellular signalling pathways, whilst their biosynthesis and action are blocked by nonsteroidal antiinflammatory drugs (NSAID). Isoprostanes are considered to be reliable markers of oxidant stress status and have been linked to inflammation, ischaemia-reperfusion, diabetes, cardiovascular disease, reproductive disorders and diabetes. (PMID: 16986207). Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. Prostaglandin B2 (PGB2) is a prostanoid. Prostanoids is a term that collectively describes prostaglandins, prostacyclines and thromboxanes. Prostanoids are a subclass of the lipid mediator group known as eicosanoids. They derive from C-20 polyunsaturated fatty acids, mainly dihomo-gamma-linoleic (20:3n-6), arachidonic (20:4n-6), and eicosapentaenoic (20:5n-3) acids, through the action of cyclooxygenases-1 and -2 (COX-1 and COX-2). The reaction product of COX is the unstable endoperoxide prostaglandin H (PGH) that is further transformed into the individual prostanoids by a series of specific prostanoid synthases. Prostanoids are local-acting mediators formed and inactivated within the same or neighbouring cells prior to their release into circulation as inactive metabolites (15-keto- and 13,14-dihydroketo metabolites). Non-enzymatic peroxidation of arachidonic acid and other fatty acids in vivo can result in prostaglandin-like substances isomeric to the COX-derived prostaglandins that are termed isoprostanes. Prostanoids take part in many physiological and pathophysiological processes in practically every organ, tissue and cell, including the vascular, renal, gastrointestinal and reproductive systems. Their activities are mediated through prostanoid-specific receptors and intracellular signalling pathways, whilst their biosynthesis and action are blocked by nonsteroidal antiinflammatory drugs (NSAID). Isoprostanes are considered to be reliable markers of oxidant stress status and have been linked to inflammation, ischaemia-reperfusion, diabetes, cardiovascular disease, reproductive disorders and diabetes. (PMID: 16986207)

   

12-Keto-leukotriene B4

(5S,6Z,8E,10E,14Z)-5-Hydroxy-12-oxoeicosa-6,8,10,14-tetraenoic acid

C20H30O4 (334.2144)


12-Keto-leukotriene B4 is formed when leukotriene B4 (LTB4) is metabolized by beta-oxidation. LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. (PMID: 8632343, 9667737)Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 12-Keto-leukotriene B4 is formed when leukotriene B4 (LTB4) is metabolized by beta-oxidation. LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. (PMID: 8632343, 9667737)

   

Prostaglandin A2

(5Z)-7-[(1R,2S)-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopent-3-en-1-yl]hept-5-enoic acid

C20H30O4 (334.2144)


Produced by the seminal vesicles, prostaglandins are a group of lipid compounds that are derived enzymatically from fatty acids. Technically hormones, the prostanoid class of fatty acid derivatives is a subclass of eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis through receptor-mediated G-protein linked signaling pathways. Prostaglandin A is a cyclopentenone and is an endogenous metabolite derived from arachidonic acid. It exhibits potent cellular anti-proliferative activity in vivo and in vitro. Excess PGA2 causes an accumulation in both S and G2/M, and a marked decrease in G1. There is also an increase in DNA content preceeding the G0/G1 peak (indicative of apoptotic body formation) mediated by changes in expression levels of Bax and Bcl-2. Produced by the seminal vessicals: Prostaglandins are a group of lipid compounds that are derived enzymatically from fattyacids. Technically a hormone, the prostanoid class of fatty acid derivatives is a subclass of eicosanoids. Prostaglandin A is cyclopentenone and endogenous metabolite derived from arachidonic acid. Exhibits potent cellular anti-proliferative activity in vivo and in vitro. Excess PGA2 causes an accumulation in both S and G2/M, and a marked decrease in G1. As well there is an increase in DNA content preceeding the G0/G1 peak (indicative of apoptic body formation) mediated by changes in expression levels of Bax and Bcl-2.

   

Prostaglandin-c2

(5Z)-7-[(1R)-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopent-2-en-1-yl]hept-5-enoic acid

C20H30O4 (334.2144)


This compound belongs to the family of Prostaglandins and related compounds. These are unsaturated carboxylic acids consisting of of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid.

   

Delta-12-Prostaglandin J2

(5Z)-7-[(1S,5E)-5-[(3S)-3-hydroxyoctylidene]-4-oxocyclopent-2-en-1-yl]hept-5-enoic acid

C20H30O4 (334.2144)


Delta-12-Prostaglandin J2 (d12-PGJ2) is the ultimate metabolite of Prostaglandin D2 (PGD2). PGD2 is an unstable molecule and undergoes dehydration to form PGJ2 in aqueous solution, and is then converted to d12-PGJ2, in the presence of serum albumin or plasma. d12-PGJ2 forms a conjugate with the thiol of glutathione (GSH) and GSH suppresses the d12-PGJ2-induced HSP synthesis and subsequent inhibition of cell growth (HSPs are a set of proteins synthesized in response to heat shock or to other environmental stresses). d12-PGJ2 has been shown to stimulate alkaline phosphatase activity and calcification of human osteoblastic cells, the potency of the PGs being comparable to that of 1-a,25-dihydroxy vitamin D. d12-PGJ2 enhances the type-1 collagen synthesis in human osteoblasts during calcification. Thus, d12-PGJ2 modulates osteogenesis through induction of the syntheses of multiple proteins related to mineralization. Considering that PGD2 is a major arachidonate metabolite in bone marrow, d12-PGJ2, may be physiologically involved in the modulation of osteogenesis. d12-PGJ2 induces heme oxygenase, HO-l. Heme oxygenase is a key enzyme in heme catabolism, oxidatively clearing heme to yield biliverdin, iron and carbon monoxide. The biological function of this enzyme is the conversion of potentially toxic heme to bile and the recovery of the iron. Furthermore, carbon monoxide produced on the enzymatic degradation of heme has been suggested to function as a neural messenger. Two isozymes of heme oxygenase, HO-l and HO-2, have been identified. HO-2 is constitutively expressed, while HO-l is drastically induced in response to a variety of stresses, including heavy metals, heat shock and UV irradiation. (PMID: 8777585)Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. delta-12-Prostaglandin J2 (d12-PGJ2) is the ultimate metabolite of Prostaglandin D2 (PGD2). PGD2 is an unstable molecule and undergoes dehydration to form PGJ2 in aqueous solution, and is then converted to d12-PGJ2, in the presence of serum albumin or plasma. d12-PGJ2 forms a conjugate with the thiol of glutathione (GSH) and GSH suppresses the d12-PGJ2-induced HSP synthesis and subsequent inhibition of cell growth (HSPs are a set of proteins synthesized in response to heat shock or to other environmental stresses). d12-PGJ2 has been shown to stimulate alkaline phosphatase activity and calcification of human osteoblastic cells, the potency of the PGs being comparable to that of 1-a,25-dihydroxy vitamin D. d12-PGJ2 enhances the type-1 collagen synthesis in human osteoblasts during calcification. Thus, d12-PGJ2 modulates osteogenesis through induction of the syntheses of multiple proteins related to mineralization. Considering that PGD2 is a major arachidonate metabolite in bone marrow, d12-PGJ2, may be physiologically involved in the modulation of osteogenesis. d12-PGJ2 induces heme oxygenase, HO-l. Heme oxygenase is a key enzyme in heme catabolism, oxidatively clearing heme to yield biliverdin, iron and carbon monoxide. The biological function of this enzyme is the conversion of potentially toxic heme to bile and the recovery of the iron. Furthermore, carbon monoxide produced on the enzymatic degradation of heme has been suggested to function as a neural messenger. Two isozymes of heme oxygenase, HO-l and HO-2, have been identified. HO-2 is constitutively expressed, while HO-l is drastically induced in response to a variety of stresses, including heavy metals, heat shock and UV irradiation. (PMID: 8777585) D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000970 - Antineoplastic Agents

   

Lathyrol

(1R,3Z,5R,7S,11R,12R,13S,14S)-1,11,13-Trihydroxy-3,6,6,14-tetramethyl-10-methylidenetricyclo[10.3.0.05,7]pentadec-3-en-2-one

C20H30O4 (334.2144)


Lathyrol is a natural product, and is used for cancer treatment. Lathyrol is a natural product, and is used for cancer treatment.

   

17-Oxogrindelic acid

17-Oxogrindelic acid

C20H30O4 (334.2144)


   

(ent-6alpha,7alpha)-6,7-Dihydroxy-16-kauren-19-oic acid

2,3-dihydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

C20H30O4 (334.2144)


(ent-6alpha,7alpha)-6,7-Dihydroxy-16-kauren-19-oic acid is found in fruits. (ent-6alpha,7alpha)-6,7-Dihydroxy-16-kauren-19-oic acid is produced by Cucurbita maxima and in cell-free systems of other plants. Production by Cucurbita maxima and in cell-free systems of other plants. 6beta,7beta-Dihydroxykaurenoic acid is found in fruits and japanese pumpkin.

   

ACMC-20m8le

(7E,9E,11Z,13E)-(5S,6S,15S)-5,6-Epoxy-15-hydroxyeicosa-7,9,11,13-tetraenoic acid

C20H30O4 (334.2144)


   

17beta-Hydroxy-4-oxa-5alpha-androstan-3-one acetate

4a,6a-dimethyl-2-oxohexadecahydroindeno[5,4-f]chromen-7-yl acetate

C20H30O4 (334.2144)


   

3beta,13-Dihydroxy-16-(hydroxymethylene)-13,17-seco-5alpha-androstan-17-oic acid, delta-lactone

3beta,13-Dihydroxy-16-(hydroxymethylene)-13,17-seco-5alpha-androstan-17-oic acid, delta-lactone

C20H30O4 (334.2144)


   

Resolvin E2

Resolvin E2; 5S,18R-Dihydroxy-6E,8Z,11Z,14Z,16E-eicosapentaenoic acid

C20H30O4 (334.2144)


A member of the class of resolvins that is (6E,8Z,11Z,14Z,16E)-icosapentaenoic acid carrying two hydroxy substituents at positions 5 and 18 (the 5S,18R stereoisomer).

   

15-Keto-13,14-dihydroprostaglandin A2

(5Z)-7-[(1R,5S)-2-oxo-5-(3-oxooctyl)cyclopent-3-en-1-yl]hept-5-enoic acid

C20H30O4 (334.2144)


13,14-dihydro-15-keto PGA2 is produced via non-enzymatic dehydration of 13,14-dihydro-15-keto PGE2. PGE2 is the most common and most biologically active of the mammalian prostaglandins. It has important effects in labour and also stimulates osteoblasts to release factors which stimulate bone resorption by osteoclasts (a type of bone cell that removes bone tissue by removing the bones mineralized matrix). (PMID: 16978535, 7384561, 7384560)Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 13,14-dihydro-15-keto PGA2 is produced via non-enzymatic dehydration of 13,14-dihydro-15-keto PGE2. PGE2 is the most common and most biologically active of the mammalian prostaglandins. It has important effects in labour and also stimulates osteoblasts to release factors which stimulate bone resorption by osteoclasts (a type of bone cell that removes bone tissue by removing the bones mineralized matrix). (PMID: 16978535, 7384561, 7384560)

   

Leukotriene B5

(5S,6Z,8E,10E,12R,14Z,17Z)-5,12-dihydroxyicosa-6,8,10,14,17-pentaenoic acid

C20H30O4 (334.2144)


Leukotriene B5 (LTB5) is a 5-lipoxygenase metabolite of arachidonic (AA) and eicosapentaenoic acid (EPA), involved in numerous inflammatory diseases and possesses a substantially less potent inflammatory effect than LTB4. Binding of LTB5 to human neutrophil LTB4 high affinity binding sites is lower than that of LTB4. Polymorphonuclear leukocytes isolated from volunteers who ingested eicosapentaenoic acid (EPA) form LTB5. Enrichment of human neutrophils with EPA, by dietary supplementation for at least 3 weeks, reduces their formation of LTB4 ex vivo. LTB5 is catabolized to 20-OH-LTB5, which in turn is metabolized to 20-COOH-LTB5. Presumably the same enzyme systems are involved in the catabolism of LTB5 that are responsible for catabolism of LTB4. Fish oil supplementation has a protective effect on exercise-induced bronchoconstriction (EIB) in elite athletes, which may be attributed to its antiinflammatory properties due to a significant reduction in LTB4 and a significant increase in LTB5 generation from activated polymorphonuclear leukocytes (PMNLs). (PMID: 1964169, 15866528, 2538061, 16424411). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. Leukotriene B5 (LTB5) is a 5-lipoxygenase metabolite of arachidonic (AA) and eicosapentaenoic acid (EPA), involved in numerous inflammatory diseases and possesses a substantially less potent inflammatory effect than LTB4. Binding of LTB5 to human neutrophil LTB4 high affinity binding sites is lower than that of LTB4. Polymorphonuclear leukocytes isolated from volunteers who ingested eicosapentaenoic acid (EPA) form LTB5. Enrichment of human neutrophils with EPA, by dietary supplementation for at least 3 weeks, reduces their formation of LTB4 ex vivo. LTB5 is catabolized to 20-OH-LTB5, which in turn is metabolized to 20-COOH-LTB5. Presumably the same enzyme systems are involved in the catabolism of LTB5 that are responsible for catabolism of LTB4. Fish oil supplementation has a protective effect on exercise-induced bronchoconstriction (EIB) in elite athletes, which may be attributed to its antiinflammatory properties due to a significant reduction in LTB4 and a significant increase in LTB5 generation from activated polymorphonuclear leukocytes (PMNLs). (PMID: 1964169, 15866528, 2538061, 16424411)

   

Dehydropinifolic acid

5-[(3Z)-4-carboxy-3-methylbut-3-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2H-naphthalene-1-carboxylic acid

C20H30O4 (334.2144)


Dehydropinifolic acid is a constituent of Pinus sylvestris (Scotch pine). Constituent of Pinus sylvestris (Scotch pine)

   

Crispanone

(1R,3AR,4R,8as)-8a-hydroxy-3a,6-dimethyl-3-oxo-1-(propan-2-yl)-1,2,3,3a,4,7,8,8a-octahydroazulen-4-yl (2Z)-2-methylbut-2-enoic acid

C20H30O4 (334.2144)


Crispanone is found in herbs and spices. Crispanone is a constituent of Petroselinum crispum (parsley). Constituent of Petroselinum crispum (parsley). Crispanone is found in herbs and spices and parsley.

   

(ent-16betaOH)-16,17-Dihydroxy-9(11)-kauren-19-oic acid

14-hydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-10-ene-5-carboxylic acid

C20H30O4 (334.2144)


(ent-16betaOH)-16,17-Dihydroxy-9(11)-kauren-19-oic acid is found in coffee and coffee products. (ent-16betaOH)-16,17-Dihydroxy-9(11)-kauren-19-oic acid is a constituent of roasted coffee.

   

8alpha-8-Hydroxy-12-oxo-13-abieten-18-oic acid

8a-hydroxy-1,4a-dimethyl-6-oxo-7-(propan-2-yl)-1,2,3,4,4a,4b,5,6,8a,9,10,10a-dodecahydrophenanthrene-1-carboxylic acid

C20H30O4 (334.2144)


8alpha-8-Hydroxy-12-oxo-13-abieten-18-oic acid is a constituent of Pinus sylvestris (Scotch pine) Constituent of Pinus sylvestris (Scotch pine)

   

Phytocassane B

2-ethenyl-5,6,7-trihydroxy-1,4b,8,8-tetramethyl-1,4,4a,4b,5,6,7,8,8a,9,10,10a-dodecahydrophenanthren-4-one

C20H30O4 (334.2144)


Phytoalexin from Oryza sativa (rice). Phytocassane B is found in cereals and cereal products and rice. Phytocassane B is found in cereals and cereal products. Phytoalexin from Oryza sativa (rice).

   

bicyclo-PGE2

(5Z)-7-[(1R,3aS,7aS)-4-butyl-2,5-dioxo-octahydro-1H-inden-1-yl]hept-5-enoic acid

C20H30O4 (334.2144)


bicyclo Prostaglandin E2 (bicyclo-PGE2) is a stable breakdown product of PGE2 and 13,14-dihydro-15-keto PGE2. Bicyclo PGE2 is a stable, base-catalyzed transformation product of 13,14-dihydro-15-keto PGE2. 13,14-dihydro-15-keto PGE2 itself is a metabolite of PGE2 found in human plasma at a median level of 20-25 pg/ml. Due to the inherent instability of 13,14-dihydro-15-keto PGE2, it is advisable to quantify it as bicyclo PGE2 to estimate PGE2 biosynthesis or metabolism in vivo. (http://bioreagent.bertinpharma.com/)

   

5-Oxo-6-trans-leukotriene B4

(6E,8E,10E,12R,14Z)-12-hydroxy-5-oxoicosa-6,8,10,14-tetraenoic acid

C20H30O4 (334.2144)


5-oxo-6-trans-leukotriene B4 is the metabolite of lipid omega-oxidation of leukotriene B4 (LTB4). LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region, and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by omega-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the omega-carboxy position and after CoA ester formation (PMID: 7649996, 17623009, 2853166, 6088485). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 5-oxo-6-trans-leukotriene B4 is the metabolite of lipid omega-oxidation of leukotriene B4 (LTB4). LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. (PMID: 7649996, 17623009, 2853166, 6088485)

   

7'-Carboxy-gamma-chromanol

(4S)-7-[(2R)-6-hydroxy-2,7,8-trimethyl-3,4-dihydro-2H-1-benzopyran-2-yl]-4-methylheptanoic acid

C20H30O4 (334.2144)


7-Carboxy-gamma-tocopherol is a dehydrogenation carboxylate product of 7-hydroxy-r-tocopherol by an unidentified microsomal enzyme(s) probably via an aldehyde intermediate. r-Tocopherol provides different antioxidant activities in food and in-vitro studies and showed higher activity in trapping lipophilic electrophiles and reactive nitrogen and oxygen species. From the metabolism end product, only that of r-tocopherol (2,7,8-trimethyl-2-(b-carboxyethyl)-6-hydroxychroman), but not that of a-tocopherol, was identified to provide natriuretic activity. Only the r-tocopherol plasma level served as biomarker for cancer and cardiovascular risk.

   

15d PGD2

(5Z)-7-[(1S,2E,5R)-5-hydroxy-2-[(2Z)-oct-2-en-1-ylidene]-3-oxocyclopentyl]hept-5-enoic acid

C20H30O4 (334.2144)


15d PGD2 is a Prostaglandin D2. Prostaglandin D2 is a prostaglandin that binds to the receptor PTGDR, as well as CRTH2. It is a major prostaglandin produced by mast cells – recruits Th2 cells, eosinophils, and basophils. (Wikipedia)

   

15-deoxy-PGD2

(5Z)-7-[(1R,2E,5S)-5-hydroxy-2-[(2E)-oct-2-en-1-ylidene]-3-oxocyclopentyl]hept-5-enoic acid

C20H30O4 (334.2144)


15-deoxy-PGD2 is classified as a member of the Prostaglandins and related compounds. Prostaglandins and related compounds are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid. 15-deoxy-PGD2 is considered to be practically insoluble (in water) and acidic. 15-deoxy-PGD2 is an eicosanoid lipid molecule

   

5-oxo-12-HETE

(6E,8Z,12S,14Z)-12-hydroxy-5-oxoicosa-6,8,10,14-tetraenoic acid

C20H30O4 (334.2144)


5-oxo-12-HETE, also known as 5-oxo-12-Hydroxy-6,8,11,13-eicosatetraenoic acid or 8-Tarns-5-oxo-12-hete, is classified as a member of the Leukotrienes. Leukotrienes are eicosanoids containing a hydroxyl group attached to the aliphatic chain of an arachidonic acid. Leukotrienes have four double bonds, three (and only three) of which are conjugated. 5-oxo-12-HETE is considered to be practically insoluble (in water) and acidic

   

5,12-dihydroxy-6,8,10,14,17-eicosapentaenoic acid

(6E,8E,10E,14E,17E)-5,12-dihydroxyicosa-6,8,10,14,17-pentaenoic acid

C20H30O4 (334.2144)


5,12-dihydroxy-6,8,10,14,17-eicosapentaenoic acid, also known as LTB 5 or Leukotriene b5, is classified as a member of the Hydroxyeicosapentaenoic acids. Hydroxyeicosapentaenoic acids are eicosanoic acids with an attached hydroxyl group and five CC double bonds. 5,12-dihydroxy-6,8,10,14,17-eicosapentaenoic acid is considered to be practically insoluble (in water) and acidic

   

(15S)-Prostaglandin A2

7-[2-(3-hydroxyoct-1-en-1-yl)-5-oxocyclopent-3-en-1-yl]hept-5-enoic acid

C20H30O4 (334.2144)


   

14-Deoxyandrographolide

3-{2-[6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-decahydronaphthalen-1-yl]ethyl}-2,5-dihydrofuran-2-one

C20H30O4 (334.2144)


   

(E)-7-[(5R)-5-[(E)-3-Hydroxyoct-1-enyl]-4-oxocyclopent-2-en-1-yl]hept-5-enoic acid

(E)-7-[(5R)-5-[(E)-3-Hydroxyoct-1-enyl]-4-oxocyclopent-2-en-1-yl]hept-5-enoic acid

C20H30O4 (334.2144)


   

(5S,12R)-5,12-Dihydroxyicosa-6,8,10,14,17-pentaenoic acid

(5S,12R)-5,12-Dihydroxyicosa-6,8,10,14,17-pentaenoic acid

C20H30O4 (334.2144)


   

(E)-7-[(1S,5E)-5-(3-Hydroxyoctylidene)-4-oxocyclopent-2-en-1-yl]hept-5-enoic acid

(E)-7-[(1S,5E)-5-(3-Hydroxyoctylidene)-4-oxocyclopent-2-en-1-yl]hept-5-enoic acid

C20H30O4 (334.2144)


   

Agathic acid

5-(4-carboxy-3-methylbut-3-en-1-yl)-1,4a-dimethyl-6-methylidene-hexahydro-2H-naphthalene-1-carboxylic acid

C20H30O4 (334.2144)


   

BICYCLO PROSTAGLANDIN E2

7-(4-butyl-2,5-dioxo-hexahydro-1H-inden-1-yl)hept-5-enoic acid

C20H30O4 (334.2144)


   

Resolvin E2

5,18-dihydroxyicosa-6,8,11,14,16-pentaenoic acid

C20H30O4 (334.2144)


   

Resolvin E3

17,18-dihydroxyicosa-5,8,11,13,15-pentaenoic acid

C20H30O4 (334.2144)


   

3,4-Dihexylphthalic Acid

3,4-dihexylbenzene-1,2-dicarboxylic acid

C20H30O4 (334.2144)


   

Prostaglandin A-2

(Z)-7-((1R,2S)-2-((e)-(3S)-3-Hydroxyoct-1-enyl)-5-oxocyclopent-3-enyl)hept-5-enoic acid

C20H30O4 (334.2144)


Prostaglandin a-2, also known as pga2 or medullin, is a member of the class of compounds known as prostaglandins and related compounds. Prostaglandins and related compounds are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid. Prostaglandin a-2 is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Prostaglandin a-2 can be found in soft-necked garlic, which makes prostaglandin a-2 a potential biomarker for the consumption of this food product.

   

Prostaglandin B-2

(5E)-7-{2-[(1E)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopent-1-en-1-yl}hept-5-enoic acid

C20H30O4 (334.2144)


Prostaglandin b-2 is a member of the class of compounds known as prostaglandins and related compounds. Prostaglandins and related compounds are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid. Prostaglandin b-2 is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Prostaglandin b-2 can be found in soft-necked garlic, which makes prostaglandin b-2 a potential biomarker for the consumption of this food product.

   

Deoxyandrographolide

3-{2-[(4aS,5R,6R,8aR)-6-Hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-3,4,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]ethyl}furan-2(5H)-one

C20H30O4 (334.2144)


Deoxyandrographolide is a natural product found in Andrographis paniculata with data available.

   

WLN91FAQ6Z

4-[2-[(1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethyl]-2H-furan-5-one

C20H30O4 (334.2144)


14-Deoxyandrographolide is a natural product found in Andrographis paniculata and Taiwanofungus camphoratus with data available. 14-Deoxyandrographolide is a labdane diterpene with calcium channel blocking activity. 14-Deoxyandrographolide desensitizes hepatocytes to TNF-α-mediated apoptosis through the release of TNFRSF1A release[1][2]. 14-Deoxyandrographolide is a labdane diterpene with calcium channel blocking activity. 14-Deoxyandrographolide desensitizes hepatocytes to TNF-α-mediated apoptosis through the release of TNFRSF1A release[1][2].

   

Kolavic acid

Kolavic acid

C20H30O4 (334.2144)


   

3-O-Angeloylcuauhtemone

[1S-[1alpha,2alpha(Z),4abeta,8aalpha]]-Decahydro-1-hydroxy-1,4a-dimethyl-7-(1-methylethylidene)-6-oxo-2-naphthalenyl ester 2-methyl-2-butenoic acid

C20H30O4 (334.2144)


   

Phomactin A

Phomactin A

C20H30O4 (334.2144)


   

Leopersin G

Leopersin G

C20H30O4 (334.2144)


   

Wangzaozin A

Wangzaozin A

C20H30O4 (334.2144)


   

Manaarenolide I

Manaarenolide I

C20H30O4 (334.2144)


   
   

Henrilabdane C

Henrilabdane C

C20H30O4 (334.2144)


   

Phyllostachysin F

Phyllostachysin F

C20H30O4 (334.2144)


   

Flexibilide

Flexibilide

C20H30O4 (334.2144)


   
   

ent-16-Hydroxy-17-oxo-7,13Z-Labdadiene-15-oic acid

ent-16-Hydroxy-17-oxo-7,13Z-Labdadiene-15-oic acid

C20H30O4 (334.2144)


   
   

17,18-Dihydroxy-2,6,10,14-phytatetraen-1,20-olide

17,18-Dihydroxy-2,6,10,14-phytatetraen-1,20-olide

C20H30O4 (334.2144)


   
   

Phlogantholide A

Phlogantholide A

C20H30O4 (334.2144)


   

1-(3,3-Dimethyloxiranyl)-7-hydroxy-3,7-dimethyl-3,5,8-nonatrienyl ester 2-methyl-2-butenoic acid

1-(3,3-Dimethyloxiranyl)-7-hydroxy-3,7-dimethyl-3,5,8-nonatrienyl ester 2-methyl-2-butenoic acid

C20H30O4 (334.2144)


   

12,20-Dihydroxy-3alpha,4alpha,15,16-bisepoxy-8beta,10betaH-ent-cleroda-13(16),14-diene

12,20-Dihydroxy-3alpha,4alpha,15,16-bisepoxy-8beta,10betaH-ent-cleroda-13(16),14-diene

C20H30O4 (334.2144)


   

Decahydro-alpha,4a-dimethyl-8-methylene-7-[(2-methyl-1-oxo-2-butenyl)oxy]-2-naphthaleneacetic acid

Decahydro-alpha,4a-dimethyl-8-methylene-7-[(2-methyl-1-oxo-2-butenyl)oxy]-2-naphthaleneacetic acid

C20H30O4 (334.2144)


   

Topsentolide B1

Topsentolide B1

C20H30O4 (334.2144)


   

Preleoheterin

Preleoheterin

C20H30O4 (334.2144)


   

Schizostatin

(E,E,E)-2-(4,8,12-Trimethyl-3,7,11-tridecatrienyl)-2-butenedioic acid

C20H30O4 (334.2144)


   

NCI60_002340

NCI60_002340

C20H30O4 (334.2144)


   

Sandensolide

Sandensolide

C20H30O4 (334.2144)


   

ent-2,3-Seco-beyer-15-ene-2,3-dioic acid

(+)-ent-2,3-Seco-beyer-15-ene-2,3-dioic acid

C20H30O4 (334.2144)


   

Hartwrightia acid

Hartwrightia acid

C20H30O4 (334.2144)


   
   

Excoecarin V2

Excoecarin V2

C20H30O4 (334.2144)


   

Decahydro-alpha,4a-dimethyl-8-methylene-7-[(3-methyl-1-oxo-2-butenyl)oxy]-2-naphthaleneacetic acid

Decahydro-alpha,4a-dimethyl-8-methylene-7-[(3-methyl-1-oxo-2-butenyl)oxy]-2-naphthaleneacetic acid

C20H30O4 (334.2144)


   

Phomactin F

Phomactin F

C20H30O4 (334.2144)


   

Leoheteronin E

Leoheteronin E

C20H30O4 (334.2144)


   

Serrulat-14-en-3,7,8,20-tetraol

Serrulat-14-en-3,7,8,20-tetraol

C20H30O4 (334.2144)


   

1(10),13E-Halimadiene-15,18-dioic acid

1(10),13E-Halimadiene-15,18-dioic acid

C20H30O4 (334.2144)


   

Crassocolide D

Crassocolide D

C20H30O4 (334.2144)


   

[R-[R*,R*-(Z,E,E,E)]]-1-(3,3-Dimethyloxiranyl)-9-hydroxy-3,7-dimethyl-3,5,7-nonatrienyl ester 2-methyl-2-butenoic acid

[R-[R*,R*-(Z,E,E,E)]]-1-(3,3-Dimethyloxiranyl)-9-hydroxy-3,7-dimethyl-3,5,7-nonatrienyl ester 2-methyl-2-butenoic acid

C20H30O4 (334.2144)


   

Caesalpinolide D

Caesalpinolide D

C20H30O4 (334.2144)


   

Acanthokoreoic acid A

Acanthokoreoic acid A

C20H30O4 (334.2144)


   

3-Oxo-18-hydroxy-8(17),13Z-labdadien-15-oic acid

3-Oxo-18-hydroxy-8(17),13Z-labdadien-15-oic acid

C20H30O4 (334.2144)


   
   

Dihydrocapsiconiate

Dihydrocapsiconiate

C20H30O4 (334.2144)


   

[4aR-(4aalpha,5alpha,6alpha,8abeta)]-4,4a,5,6,7,8,8a,9-Octahydro-5-hydroxy-3,5,8a-trimethylnaphtho[2,3-b]furan-6-yl ester3-methylbutanoic acid

[4aR-(4aalpha,5alpha,6alpha,8abeta)]-4,4a,5,6,7,8,8a,9-Octahydro-5-hydroxy-3,5,8a-trimethylnaphtho[2,3-b]furan-6-yl ester3-methylbutanoic acid

C20H30O4 (334.2144)


   

(1R,2R,4R,8S,9R,10S,13S,16R)-2,8,16-trihydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0^{1,10.0^{4,9]hexadecan-15-one

(1R,2R,4R,8S,9R,10S,13S,16R)-2,8,16-trihydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0^{1,10.0^{4,9]hexadecan-15-one

C20H30O4 (334.2144)


   
   

6-Oxogrindelic acid

6-Oxogrindelic acid

C20H30O4 (334.2144)


   

Isoscoparin L

Isoscoparin L

C20H30O4 (334.2144)


   

Manaarenolide G

Manaarenolide G

C20H30O4 (334.2144)


   

Pachyclavulariolide N

Pachyclavulariolide N

C20H30O4 (334.2144)


   
   
   

Batudioic acid

Batudioic acid

C20H30O4 (334.2144)


   

3alpha,12-Dihydroxy-4alpha,20,15,16-bisepoxy-8beta,10betaH-ent-cleroda-13(16),14-diene

3alpha,12-Dihydroxy-4alpha,20,15,16-bisepoxy-8beta,10betaH-ent-cleroda-13(16),14-diene

C20H30O4 (334.2144)


   

16-Hydroxy-6-oxo-7,ent-13E-labdasien-15-oic acid

16-Hydroxy-6-oxo-7,ent-13E-labdasien-15-oic acid

C20H30O4 (334.2144)


   

8alphaH,ent-3eta,17-Dioxo-13Z-labden-15-oic acid

8alphaH,ent-3eta,17-Dioxo-13Z-labden-15-oic acid

C20H30O4 (334.2144)


   

Chapecoderin A

Chapecoderin A

C20H30O4 (334.2144)


   

Enanderianin P

Enanderianin P

C20H30O4 (334.2144)


   

ent-2alpha-2,18-Dihydroxy-8(17),13-labdadien-15,16-olide

ent-2alpha-2,18-Dihydroxy-8(17),13-labdadien-15,16-olide

C20H30O4 (334.2144)


   
   

Cymbodiacetal

Cymbodiacetal

C20H30O4 (334.2144)


   

7,13(16)-Labdadiene-15,19-dioic acid

7,13(16)-Labdadiene-15,19-dioic acid

C20H30O4 (334.2144)


   

ent-8beta,17-Epoxy-3-oxo-13Z-labden-15-oic acid

ent-8beta,17-Epoxy-3-oxo-13Z-labden-15-oic acid

C20H30O4 (334.2144)


   

18-Oxogrindelic acid

18-Oxogrindelic acid

C20H30O4 (334.2144)


   
   

Neoallocyathin A4

Neoallocyathin A4

C20H30O4 (334.2144)


   

Excoecarin V1

Excoecarin V1

C20H30O4 (334.2144)


   

Alboatisin C

Alboatisin C

C20H30O4 (334.2144)


   

Chapecoderin B

Chapecoderin B

C20H30O4 (334.2144)


   

Caesalpinolide C

Caesalpinolide C

C20H30O4 (334.2144)


   

8betaH,ent-3eta,17-Dioxo-13Z-labden-15-oic acid

8betaH,ent-3eta,17-Dioxo-13Z-labden-15-oic acid

C20H30O4 (334.2144)


   

Guamaiac acid

ent-8(17),13-labdadien-15,18-dioic acid

C20H30O4 (334.2144)


   

1(10),13Z-Halimadiene-15,18-dioic acid

1(10),13Z-Halimadiene-15,18-dioic acid

C20H30O4 (334.2144)


   

Haplopappic acid

Haplopappic acid

C20H30O4 (334.2144)


   

16,18-Dihydroxy-2,6,10,14-phytatetraen-1,20-olide

16,18-Dihydroxy-2,6,10,14-phytatetraen-1,20-olide

C20H30O4 (334.2144)


   

6,18,19-Trihydroxytrachyloban-2-one

6,18,19-Trihydroxytrachyloban-2-one

C20H30O4 (334.2144)


   

DTXSID40904194

DTXSID40904194

C20H30O4 (334.2144)


   

13,14-Dihydro-15-keto Prostaglandin J2

13,14-Dihydro-15-keto Prostaglandin J2

C20H30O4 (334.2144)


   
   

ent-kauran-17,19-dioic acid

ent-kauran-17,19-dioic acid

C20H30O4 (334.2144)


   

MEGxp0_000761

MEGxp0_000761

C20H30O4 (334.2144)


   

MCULE-9907524398

MCULE-9907524398

C20H30O4 (334.2144)


   

(E)-5-[(1S,8aS)-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-(hydroxymethyl)-2-oxopent-3-enoic acid

(E)-5-[(1S,8aS)-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-(hydroxymethyl)-2-oxopent-3-enoic acid

C20H30O4 (334.2144)


   

MCULE-2060297166

MCULE-2060297166

C20H30O4 (334.2144)


   

(2alpha,6alpha)-2,6-Dihydroxy-8,13-labdadien-15,16-olide

(2alpha,6alpha)-2,6-Dihydroxy-8,13-labdadien-15,16-olide

C20H30O4 (334.2144)


   

ent-12alpha,15alpha-dihydroxy-kaur-16-en-19-saure|Pterokaurene L4

ent-12alpha,15alpha-dihydroxy-kaur-16-en-19-saure|Pterokaurene L4

C20H30O4 (334.2144)


   

portulide|portulide B

portulide|portulide B

C20H30O4 (334.2144)


   

9beta-hydroxy-3alpha-tigloyloxyeremophil-7(11)-en-8-one

9beta-hydroxy-3alpha-tigloyloxyeremophil-7(11)-en-8-one

C20H30O4 (334.2144)


   

(3E,7Z,11Z)-17,20-dihydroxycembra-3,7,11,15-tetraen-19-oic acid|11,12(Z)-Didehydro,17-hydroxy-(1R*,3E,7Z,12R*)-20-Hydroxy-3,7,15-cembratrien-19-oic acid

(3E,7Z,11Z)-17,20-dihydroxycembra-3,7,11,15-tetraen-19-oic acid|11,12(Z)-Didehydro,17-hydroxy-(1R*,3E,7Z,12R*)-20-Hydroxy-3,7,15-cembratrien-19-oic acid

C20H30O4 (334.2144)


   

6alpha-hydroxy-7-oxo-ent-clerodan-3,13E-dien-15-oic acid|7-Ketone-6,7-Dihydroxy-3,13-clerodadien-15-oic acid

6alpha-hydroxy-7-oxo-ent-clerodan-3,13E-dien-15-oic acid|7-Ketone-6,7-Dihydroxy-3,13-clerodadien-15-oic acid

C20H30O4 (334.2144)


   

neodolabelline

neodolabelline

C20H30O4 (334.2144)


   

excisanin C

excisanin C

C20H30O4 (334.2144)


   

cheloviolene A

cheloviolene A

C20H30O4 (334.2144)


   

14-deoxo-14beta-hydroxy-(4E)-jatrogrossidentadione|multifolone

14-deoxo-14beta-hydroxy-(4E)-jatrogrossidentadione|multifolone

C20H30O4 (334.2144)


   

Isodopharicin D

Isodopharicin D

C20H30O4 (334.2144)


   

6alpha,18-dihydroxy-cis-cleroda-3,13(14)-diene-15,16-olide

6alpha,18-dihydroxy-cis-cleroda-3,13(14)-diene-15,16-olide

C20H30O4 (334.2144)


   

cuauthemone-3-O-senecioate

cuauthemone-3-O-senecioate

C20H30O4 (334.2144)


   

(-)-3beta,16alpha-dihydroxycleroda-4(18),13(14)Z-dien-15,16-olide|(ent-3alpha,16R)-3,16-Dihydroxy-4(18),13-clerodadien-16,15-olide|3beta,16alpha-dihydroxycleroda-4(18),13(14)-dien-15,16-olide|3beta,16alpha-dihydroxycleroda-4(18),13(14)-Z-dien-15,16-olide|3beta,16alpha-dihydroxycleroda-4(18),13(14)Z-dien-15,16-olide

(-)-3beta,16alpha-dihydroxycleroda-4(18),13(14)Z-dien-15,16-olide|(ent-3alpha,16R)-3,16-Dihydroxy-4(18),13-clerodadien-16,15-olide|3beta,16alpha-dihydroxycleroda-4(18),13(14)-dien-15,16-olide|3beta,16alpha-dihydroxycleroda-4(18),13(14)-Z-dien-15,16-olide|3beta,16alpha-dihydroxycleroda-4(18),13(14)Z-dien-15,16-olide

C20H30O4 (334.2144)


   

guanacastepene C

guanacastepene C

C20H30O4 (334.2144)


   

2alpha-hydroxy-8beta-isovaleryloxy-guaia-4,11-diene-3-one

2alpha-hydroxy-8beta-isovaleryloxy-guaia-4,11-diene-3-one

C20H30O4 (334.2144)


   

3-Oxo-ayapanonsaeuremethylester

3-Oxo-ayapanonsaeuremethylester

C20H30O4 (334.2144)


   

15(S)-16-hydroxy-8alpha-hydroperoxy-ent-abieta-9(11),13(14)-dien-12-one|glutinosin C

15(S)-16-hydroxy-8alpha-hydroperoxy-ent-abieta-9(11),13(14)-dien-12-one|glutinosin C

C20H30O4 (334.2144)


   

Leucothol C

Leucothol C

C20H30O4 (334.2144)


   

xenialactol-D

xenialactol-D

C20H30O4 (334.2144)


   
   

NCI60_002318

NCI60_002318

C20H30O4 (334.2144)


   

(2R*,3S*,6R*,7S*,10R*,13R*)-7,13-dihydroxy-2,6-cyclo-1(9),14-xenicadiene-18,19-dial

(2R*,3S*,6R*,7S*,10R*,13R*)-7,13-dihydroxy-2,6-cyclo-1(9),14-xenicadiene-18,19-dial

C20H30O4 (334.2144)


   

(1S*,9R*,11S*,12R*,4E)-12,15-epidioxy-xeniaphylla-4,8(19),13-trien-12,17-diol|sinugibberoside F

(1S*,9R*,11S*,12R*,4E)-12,15-epidioxy-xeniaphylla-4,8(19),13-trien-12,17-diol|sinugibberoside F

C20H30O4 (334.2144)


   

9alpha-angeloyloxy-10beta-hydroxy-7-epi-3E-agerafastin

9alpha-angeloyloxy-10beta-hydroxy-7-epi-3E-agerafastin

C20H30O4 (334.2144)


   

1,7alpha,14beta-trihydroxy-1,10-seco-ent-kaur-10,16-dien-15-one|luanchunin B

1,7alpha,14beta-trihydroxy-1,10-seco-ent-kaur-10,16-dien-15-one|luanchunin B

C20H30O4 (334.2144)


   

12-(2-hydroxy-2-methylbutyryloxy)-guaia-4,11-dien-3-one|12-<2-hydroxy-2-methylbutyryloxy>-guaia-4,11-dien-3-one

12-(2-hydroxy-2-methylbutyryloxy)-guaia-4,11-dien-3-one|12-<2-hydroxy-2-methylbutyryloxy>-guaia-4,11-dien-3-one

C20H30O4 (334.2144)


   

NCI60_009466

NCI60_009466

C20H30O4 (334.2144)


   

(9alpha,13R):15,16-diepoxy-6beta-hydroxylabd-14-en-7-one|iso-preleoheterin

(9alpha,13R):15,16-diepoxy-6beta-hydroxylabd-14-en-7-one|iso-preleoheterin

C20H30O4 (334.2144)


   

undecyl 3-(3,4-dihydroxyphenyl)prop-2-enoate

undecyl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C20H30O4 (334.2144)


   

ent-5alpha,2,15-dioxodolabr-3-ene-3,16-diol

ent-5alpha,2,15-dioxodolabr-3-ene-3,16-diol

C20H30O4 (334.2144)


   

2beta-hydroxy-3,4-epoxy-5beta,10beta-cis-17alpha,20alpha-cleroda-13(14)-en-15,16-olide|3beta,4beta-Epoxide-(ent-2alpha,5alpha)-2-Hydroxy-3,13-clerodadien-15,16-olide

2beta-hydroxy-3,4-epoxy-5beta,10beta-cis-17alpha,20alpha-cleroda-13(14)-en-15,16-olide|3beta,4beta-Epoxide-(ent-2alpha,5alpha)-2-Hydroxy-3,13-clerodadien-15,16-olide

C20H30O4 (334.2144)


   

14,15-Dihydro,15,17-didehydro,14-hydroxy-Ichthyouleolide|14-hydroxy-15,17-dehydro-14,15-dihydroichthyouleolide

14,15-Dihydro,15,17-didehydro,14-hydroxy-Ichthyouleolide|14-hydroxy-15,17-dehydro-14,15-dihydroichthyouleolide

C20H30O4 (334.2144)


   
   

cymathere ether B

cymathere ether B

C20H30O4 (334.2144)


   

2-Dehydro-eurupestrol-9-angelicat

2-Dehydro-eurupestrol-9-angelicat

C20H30O4 (334.2144)


   

13S-Alcohol-(1xi,2xi,6E,10E)-1,2-Epoxy-13-oxo-6,10,14-phytatrien-20,1-olide|epoxyeleganolactone

13S-Alcohol-(1xi,2xi,6E,10E)-1,2-Epoxy-13-oxo-6,10,14-phytatrien-20,1-olide|epoxyeleganolactone

C20H30O4 (334.2144)


   

3alpha,6beta-dihydroxy-7,17-dioxo-ent-abieta-15(16)-ene

3alpha,6beta-dihydroxy-7,17-dioxo-ent-abieta-15(16)-ene

C20H30O4 (334.2144)


A natural product found in Isodon eriocalyx.

   

2-methylbutyryloxy-germacra-trans,trans-1(10),4,11-trien-12-oic acid

2-methylbutyryloxy-germacra-trans,trans-1(10),4,11-trien-12-oic acid

C20H30O4 (334.2144)


   

12beta-Hydroxy-ent-16-Hydroxy-8(14)-pimarene-3,15-dione

12beta-Hydroxy-ent-16-Hydroxy-8(14)-pimarene-3,15-dione

C20H30O4 (334.2144)


   

6,8-Dihydroxy-abietinsaeure(?)

6,8-Dihydroxy-abietinsaeure(?)

C20H30O4 (334.2144)


   

15-Epimer-Cheloviolene A

15-Epimer-Cheloviolene A

C20H30O4 (334.2144)


   

(ent-2beta,6beta)-2,6-Dihydroxy-4(18),13-clerodadien-16,15-olide|scutedrummonin

(ent-2beta,6beta)-2,6-Dihydroxy-4(18),13-clerodadien-16,15-olide|scutedrummonin

C20H30O4 (334.2144)


   

Phorbasin B

Phorbasin B

C20H30O4 (334.2144)


   

(13alphaH,14betaH)-jeunicin

(13alphaH,14betaH)-jeunicin

C20H30O4 (334.2144)


   

Ecklonialactone F

Ecklonialactone F

C20H30O4 (334.2144)


   

1,9-Dihydroxycrenulide

1,9-Dihydroxycrenulide

C20H30O4 (334.2144)


   

(5Z,13E,15S)-15-hydroxy-9-oxo-prosta-5,8(12),13-trien-1-oic acid

(5Z,13E,15S)-15-hydroxy-9-oxo-prosta-5,8(12),13-trien-1-oic acid

C20H30O4 (334.2144)


   

2-hydroxy-5-methoxy-3-(Z-8-tridecenyl)-1,4-benzoquinone|5-methoxy-2-hydroxy-3-(Z-8-tridecenyl)-1,4-benzoquinone|ardisianone B

2-hydroxy-5-methoxy-3-(Z-8-tridecenyl)-1,4-benzoquinone|5-methoxy-2-hydroxy-3-(Z-8-tridecenyl)-1,4-benzoquinone|ardisianone B

C20H30O4 (334.2144)


   

pilosanone C

pilosanone C

C20H30O4 (334.2144)


   

spongiabutenolide D

spongiabutenolide D

C20H30O4 (334.2144)


   

ent-clerod-3-en-15-oic acid-18,19-olide

ent-clerod-3-en-15-oic acid-18,19-olide

C20H30O4 (334.2144)


   

13,14-dihydro-marrubiagenine|13,14-dihydromarrubiagenine

13,14-dihydro-marrubiagenine|13,14-dihydromarrubiagenine

C20H30O4 (334.2144)


   

(6E,10E)-3,12-dihydroxy-3,7,11,15-tetramethyl-1,6,10,14-hexadecatetraen-5,13-dione

(6E,10E)-3,12-dihydroxy-3,7,11,15-tetramethyl-1,6,10,14-hexadecatetraen-5,13-dione

C20H30O4 (334.2144)


   

7beta-hydroxy-11beta,16beta-epoxy-ent-kauran-19-oic acid

7beta-hydroxy-11beta,16beta-epoxy-ent-kauran-19-oic acid

C20H30O4 (334.2144)


   

ent-Labda-8(17),13Z-dien-15,19-dioic acid

ent-Labda-8(17),13Z-dien-15,19-dioic acid

C20H30O4 (334.2144)


   

(ent-15R)-form-15,16-Dihydroxy-3-erythroxylene-2,7-dione|2,7-dioxofagonene

(ent-15R)-form-15,16-Dihydroxy-3-erythroxylene-2,7-dione|2,7-dioxofagonene

C20H30O4 (334.2144)


   

Grayanotoxin XV|grayanotoxin-XV

Grayanotoxin XV|grayanotoxin-XV

C20H30O4 (334.2144)


   

NCI60_002546

NCI60_002546

C20H30O4 (334.2144)


   

(2S)-serrulat-14-ene-2,7,8,20-tetraol|2,7,8,20-tetrahydroxyserrulat-14-ene

(2S)-serrulat-14-ene-2,7,8,20-tetraol|2,7,8,20-tetrahydroxyserrulat-14-ene

C20H30O4 (334.2144)


   

isovaleryloxy-germacra-trans,trans-1(10),4,11-trien-12-oic acid

isovaleryloxy-germacra-trans,trans-1(10),4,11-trien-12-oic acid

C20H30O4 (334.2144)


   

2-Hydroxy-5-methoxy-3-tridecenyl-benzochinon|2-Hydroxy-5-methoxy-3-tridecenylbenzochinon

2-Hydroxy-5-methoxy-3-tridecenyl-benzochinon|2-Hydroxy-5-methoxy-3-tridecenylbenzochinon

C20H30O4 (334.2144)


   

9,10-dihydroxy-9,10-secoabieta-8,11,13-trien-18-oic acid|abiesadine B

9,10-dihydroxy-9,10-secoabieta-8,11,13-trien-18-oic acid|abiesadine B

C20H30O4 (334.2144)


   

Dendrillol 1

Dendrillol 1

C20H30O4 (334.2144)


   

Coronarin B

Coronarin B

C20H30O4 (334.2144)


   

15-(3-hydroxyisovaleryloxy)-cyperen-3-one|15-<3-hydroxyisovaleryloxy>-cyperen-3-one

15-(3-hydroxyisovaleryloxy)-cyperen-3-one|15-<3-hydroxyisovaleryloxy>-cyperen-3-one

C20H30O4 (334.2144)


   

ent-1beta-hydroxykaur-16beta(H)-15-one-19-oic acid

ent-1beta-hydroxykaur-16beta(H)-15-one-19-oic acid

C20H30O4 (334.2144)


   

6alpha,13beta-dihydroxy-7-oxoabieta-8(14)-en-19-al

6alpha,13beta-dihydroxy-7-oxoabieta-8(14)-en-19-al

C20H30O4 (334.2144)


   

chandonanthone

chandonanthone

C20H30O4 (334.2144)


   

16-Acetoxy-8,12-epoxy-14-oxo-12-labden-15-al

16-Acetoxy-8,12-epoxy-14-oxo-12-labden-15-al

C20H30O4 (334.2144)


   

Constanolactone G

Constanolactone G

C20H30O4 (334.2144)


   
   

13-(3,4-Methylene-dioxyphenyl)-tridecanoic acid|13-(3,4-methylenedioxyphenyl)-tridecanoic acid|13-(3,4-methylenedioxyphenyl)tridecanoic acid

13-(3,4-Methylene-dioxyphenyl)-tridecanoic acid|13-(3,4-methylenedioxyphenyl)-tridecanoic acid|13-(3,4-methylenedioxyphenyl)tridecanoic acid

C20H30O4 (334.2144)


   

12-(3-hydroxyisovaleryloxy)-guaia-4,11-diene-3-one|12-<3-hydroxyisovaleryloxy>-guaia-4,11-diene-3-one

12-(3-hydroxyisovaleryloxy)-guaia-4,11-diene-3-one|12-<3-hydroxyisovaleryloxy>-guaia-4,11-diene-3-one

C20H30O4 (334.2144)


   

15-hydroxy-7-ketodehydroabietic acid

15-hydroxy-7-ketodehydroabietic acid

C20H30O4 (334.2144)


   

sinugibberoside D

sinugibberoside D

C20H30O4 (334.2144)


   

flabellatene A

flabellatene A

C20H30O4 (334.2144)


   

ent-7alpha,12beta-dihydroxykaurenoic acid

ent-7alpha,12beta-dihydroxykaurenoic acid

C20H30O4 (334.2144)


   

14-Angeloyl 鈥樎?6alpha,7beta,8alpha)-6,7-Epoxy-3(15)-caryophyllene-8,14-diol

14-Angeloyl 鈥樎?6alpha,7beta,8alpha)-6,7-Epoxy-3(15)-caryophyllene-8,14-diol

C20H30O4 (334.2144)


   

(ent-11alpha,16alpha)-11-Hydroxy-15-oxo-kauranoic acid|(ent-11alpha,16beta)-11-Hydroxy-15-oxo-kauranoic acid

(ent-11alpha,16alpha)-11-Hydroxy-15-oxo-kauranoic acid|(ent-11alpha,16beta)-11-Hydroxy-15-oxo-kauranoic acid

C20H30O4 (334.2144)


   

rabdokunmin B|rabdokunmins B

rabdokunmin B|rabdokunmins B

C20H30O4 (334.2144)


   
   

NCIOpen2_009226

NCIOpen2_009226

C20H30O4 (334.2144)


   

symphyogynolide

symphyogynolide

C20H30O4 (334.2144)


   

spongiabutenolide C

spongiabutenolide C

C20H30O4 (334.2144)


   

(1S,3S,4R,7E,11E,14S)-4,14-Dihydroxy-7,11,15(17)-cembratrien-16,3-olide

(1S,3S,4R,7E,11E,14S)-4,14-Dihydroxy-7,11,15(17)-cembratrien-16,3-olide

C20H30O4 (334.2144)


   

Cadlinolide B

Cadlinolide B

C20H30O4 (334.2144)


   

15-oxolaba-13(14)-epoxy-8(17)-en-19-oic acid

15-oxolaba-13(14)-epoxy-8(17)-en-19-oic acid

C20H30O4 (334.2144)


   

Grayanotoxin|Grayanotoxin VIII

Grayanotoxin|Grayanotoxin VIII

C20H30O4 (334.2144)


   

Mulinic acid

Mulinic acid

C20H30O4 (334.2144)


   

rel-(3R,4S,5R,7S,9R)-3-hydroxy-9-(3-methylbutanoyloxy)solavetivone

rel-(3R,4S,5R,7S,9R)-3-hydroxy-9-(3-methylbutanoyloxy)solavetivone

C20H30O4 (334.2144)


   

7alpha,8alpha:13beta,14beta-diepoxyabietan-18-oic acid

7alpha,8alpha:13beta,14beta-diepoxyabietan-18-oic acid

C20H30O4 (334.2144)


   

1alpha,11beta,14beta-trihydroxy-ent-kaur-16-en-15-one|phyllostachysin H

1alpha,11beta,14beta-trihydroxy-ent-kaur-16-en-15-one|phyllostachysin H

C20H30O4 (334.2144)


   

(1R,2R,3aR,4S,7aS)-3a,4-dimethyl-4-methylene-2-oxodecahydro-2H-spiro[furan-3,2-indene]-1-yl 3-methylbutanoate|bakkenolide J|bakkenolide-J

(1R,2R,3aR,4S,7aS)-3a,4-dimethyl-4-methylene-2-oxodecahydro-2H-spiro[furan-3,2-indene]-1-yl 3-methylbutanoate|bakkenolide J|bakkenolide-J

C20H30O4 (334.2144)


   

13S-hydroxy-9-oxo-9,10-seco-abiet-8(14)-en-18,10a-olide|13S-Hydroxy-9-oxo-9,10-seco-abiet-8(14)-en-18,10??-olide

13S-hydroxy-9-oxo-9,10-seco-abiet-8(14)-en-18,10a-olide|13S-Hydroxy-9-oxo-9,10-seco-abiet-8(14)-en-18,10??-olide

C20H30O4 (334.2144)


   

10??-Hydroxyfuranoeremophilan-6??-yl-2?鈥?methylbutanoate|6beta-(2-methylbutyryloxy)furanoeremophilan-10beta-ol

10??-Hydroxyfuranoeremophilan-6??-yl-2?鈥?methylbutanoate|6beta-(2-methylbutyryloxy)furanoeremophilan-10beta-ol

C20H30O4 (334.2144)


   

13beta,14beta-Epoxy-8-secoabietan-7,19-olide|secojuniperolide

13beta,14beta-Epoxy-8-secoabietan-7,19-olide|secojuniperolide

C20H30O4 (334.2144)


   

16-hydroxy-18-oxo-kolavenic acid

16-hydroxy-18-oxo-kolavenic acid

C20H30O4 (334.2144)


   

8-hydroxy-7-oxo-15-isopimaren-18-oic acid|8beta-hydroxy-7-oxo-15-isopimaren-18-oic acid

8-hydroxy-7-oxo-15-isopimaren-18-oic acid|8beta-hydroxy-7-oxo-15-isopimaren-18-oic acid

C20H30O4 (334.2144)


   

1??, 11??-Dihydroxysacculatanolide

1??, 11??-Dihydroxysacculatanolide

C20H30O4 (334.2144)


   

cyanthiwigin T

cyanthiwigin T

C20H30O4 (334.2144)


   

1,6-geranylgeranodioic acid

1,6-geranylgeranodioic acid

C20H30O4 (334.2144)


   

9-angeloyloxy-7-hydroxy-10,11-epoxy-6,7,10,11-tetrahydro-3Z-alpha-farnesene

9-angeloyloxy-7-hydroxy-10,11-epoxy-6,7,10,11-tetrahydro-3Z-alpha-farnesene

C20H30O4 (334.2144)


   

16-hydroxycleroda-13-ene-15,16-olide-3-one

16-hydroxycleroda-13-ene-15,16-olide-3-one

C20H30O4 (334.2144)


   
   

gibberosin B

gibberosin B

C20H30O4 (334.2144)


   

1alpha,10alpha-epoxy-2-oxogagonene

1alpha,10alpha-epoxy-2-oxogagonene

C20H30O4 (334.2144)


   

11,15-Dihydroxy-16-kauren-19-oic acid

11,15-Dihydroxy-16-kauren-19-oic acid

C20H30O4 (334.2144)


   

1,20-Dihydroxy-2,6,10,14-phytatetraen-18,9-olide|20-Hydroxygeranyl geraniol-9,18-olide

1,20-Dihydroxy-2,6,10,14-phytatetraen-18,9-olide|20-Hydroxygeranyl geraniol-9,18-olide

C20H30O4 (334.2144)


   

Butyl octyl phthalate

Butyl octyl phthalate

C20H30O4 (334.2144)


   

Membrenone C

Membrenone C

C20H30O4 (334.2144)


   

EUPUTALBOLIDE

EUPUTALBOLIDE

C20H30O4 (334.2144)


   

dichotodione

dichotodione

C20H30O4 (334.2144)


   

2alpha-angeloyloxy-5beta-hydroxy-7alphaH,10betaMe-eudesm-3-en-1-one

2alpha-angeloyloxy-5beta-hydroxy-7alphaH,10betaMe-eudesm-3-en-1-one

C20H30O4 (334.2144)


   

ent-7beta-hydroxy-15beta,16beta-epoxykauran-19-oic acid

ent-7beta-hydroxy-15beta,16beta-epoxykauran-19-oic acid

C20H30O4 (334.2144)


   

Trifolione D

Trifolione D

C20H30O4 (334.2144)


   

(1R,3S,4S,7E,11Z)-3,15-epoxy-19-oxocembra-7,11-dien-18-oic acid

(1R,3S,4S,7E,11Z)-3,15-epoxy-19-oxocembra-7,11-dien-18-oic acid

C20H30O4 (334.2144)


   

4-hydroxydictyolactone (6R,7R)-epoxide

4-hydroxydictyolactone (6R,7R)-epoxide

C20H30O4 (334.2144)


   

(ent-15alpha)-9, 15-Dihydroxy-16-kauren-19-oic acid|ent-9,15alpha-dihydroxy-kaur-16-en-19-saeure

(ent-15alpha)-9, 15-Dihydroxy-16-kauren-19-oic acid|ent-9,15alpha-dihydroxy-kaur-16-en-19-saeure

C20H30O4 (334.2144)


   

(ent-14alpha,15alpha)-14,15-Dihydroxy-16,17-epoxy-12-cleistanthen-11-one|14beta,15beta-dihydroxy-16,17-oxidocleistanth-12-en-11-one

(ent-14alpha,15alpha)-14,15-Dihydroxy-16,17-epoxy-12-cleistanthen-11-one|14beta,15beta-dihydroxy-16,17-oxidocleistanth-12-en-11-one

C20H30O4 (334.2144)


   

ACMC-20m62a

ACMC-20m62a

C20H30O4 (334.2144)


   

(5beta,8xi,10alpha,13beta,14alpha)-14-hydroxy-12-oxoabiet-9(11)-en-19-oic acid|macrophynin F

(5beta,8xi,10alpha,13beta,14alpha)-14-hydroxy-12-oxoabiet-9(11)-en-19-oic acid|macrophynin F

C20H30O4 (334.2144)


   

8,14-dioxo-8,14-seco-abiet-13(15)-en-18-oic acid

8,14-dioxo-8,14-seco-abiet-13(15)-en-18-oic acid

C20H30O4 (334.2144)


   

rubesanolide B

rubesanolide B

C20H30O4 (334.2144)


   

rubesanolide A

rubesanolide A

C20H30O4 (334.2144)


   

laevigatol A

laevigatol A

C20H30O4 (334.2144)


   

ent-9-Hydroxy-15-oxokauran-19-oic acid

ent-9-Hydroxy-15-oxokauran-19-oic acid

C20H30O4 (334.2144)


   

cladielloide D

cladielloide D

C20H30O4 (334.2144)


   

eutypellone A|pimara-8,15-diene-1beta,7beta,14alpha-triol-6-one

eutypellone A|pimara-8,15-diene-1beta,7beta,14alpha-triol-6-one

C20H30O4 (334.2144)


   

1beta,3beta,9alpha-trihydroxyisopimara-8(14),15-dien-7-one|smardaesidin D

1beta,3beta,9alpha-trihydroxyisopimara-8(14),15-dien-7-one|smardaesidin D

C20H30O4 (334.2144)


   

(-)-(1S*,4S*,10R*)-1,4-dihydroxycembra-2E,7E,11Z-trien-20,10-olide

(-)-(1S*,4S*,10R*)-1,4-dihydroxycembra-2E,7E,11Z-trien-20,10-olide

C20H30O4 (334.2144)


   

trigohetone

trigohetone

C20H30O4 (334.2144)


   

(4beta,8alpha)-4,4-O,8,8-O-tetrahydrocrinipellin B|5b,6-epoxydodecahydro-3-isopropyl-3a,5a-dimethyl-8-methylene-1H-pentaleno[1,6a-a]pentalene-4,5,7-triol|rel-(1aR,2S,3aR,4aR,7R,7aR,8R,9R,9aR,9bR)-decahydro-7a,9a-dimethyl-3-methylene-7-(1-methylethyl)-3H,5H-pentaleno[6a,1: 5,6]pentaleno[1,6a-b]oxirene-2,8,9-triol

(4beta,8alpha)-4,4-O,8,8-O-tetrahydrocrinipellin B|5b,6-epoxydodecahydro-3-isopropyl-3a,5a-dimethyl-8-methylene-1H-pentaleno[1,6a-a]pentalene-4,5,7-triol|rel-(1aR,2S,3aR,4aR,7R,7aR,8R,9R,9aR,9bR)-decahydro-7a,9a-dimethyl-3-methylene-7-(1-methylethyl)-3H,5H-pentaleno[6a,1: 5,6]pentaleno[1,6a-b]oxirene-2,8,9-triol

C20H30O4 (334.2144)


   

(E)-labda-8(17),12-diene-15,16-dioic acid|5S,9S,10S-(+)-(E)-labda-8(17),12-diene-15,16-dioic acid

(E)-labda-8(17),12-diene-15,16-dioic acid|5S,9S,10S-(+)-(E)-labda-8(17),12-diene-15,16-dioic acid

C20H30O4 (334.2144)


   

scapanialide C

scapanialide C

C20H30O4 (334.2144)


   

3alpha,14beta,15beta-trihydroxy-ent-atis-16-en-7-one|isorothornin D

3alpha,14beta,15beta-trihydroxy-ent-atis-16-en-7-one|isorothornin D

C20H30O4 (334.2144)


   

scopararane G

scopararane G

C20H30O4 (334.2144)


   

6beta,20:8beta,20-diepoxyisopimar-15-ene-2alpha,7beta-diol|graciliflorin C

6beta,20:8beta,20-diepoxyisopimar-15-ene-2alpha,7beta-diol|graciliflorin C

C20H30O4 (334.2144)


   

dysoxydenone A

dysoxydenone A

C20H30O4 (334.2144)


   

sarcophytonin F

sarcophytonin F

C20H30O4 (334.2144)


   

norleucosceptroid C

norleucosceptroid C

C20H30O4 (334.2144)


   

11alpha,12beta-epoxy-5alpha-hydroxy-1betaH,2alphaH-casba-3Z,7E-dien-18-oic acid|pekinenin E

11alpha,12beta-epoxy-5alpha-hydroxy-1betaH,2alphaH-casba-3Z,7E-dien-18-oic acid|pekinenin E

C20H30O4 (334.2144)


   

(4?2)-abeo-cleroda-2,13(E)-dien-2,14-dioic acid

(4?2)-abeo-cleroda-2,13(E)-dien-2,14-dioic acid

C20H30O4 (334.2144)


   

14beta,15beta,18-trihydroxy-ent-kaur-16-en-7-one|wikstroemioidin S

14beta,15beta,18-trihydroxy-ent-kaur-16-en-7-one|wikstroemioidin S

C20H30O4 (334.2144)


   

rubesanolide C

rubesanolide C

C20H30O4 (334.2144)


   

sinumaximol D

sinumaximol D

C20H30O4 (334.2144)


   

3beta,11beta,15beta-trihydroxy-ent-kaur-16-en-6-one|tenuifolin E

3beta,11beta,15beta-trihydroxy-ent-kaur-16-en-6-one|tenuifolin E

C20H30O4 (334.2144)


   

3beta,18-dihydroxylabda-8(17),13-dien-15,16-olide

3beta,18-dihydroxylabda-8(17),13-dien-15,16-olide

C20H30O4 (334.2144)


   

7alpha,12alpha,18-trihydroxy-ent-kaur-16-en-15-one|wikstroemioidin H

7alpha,12alpha,18-trihydroxy-ent-kaur-16-en-15-one|wikstroemioidin H

C20H30O4 (334.2144)


   

14,16-epoxy-1beta,15alpha-dihydroxy-ent-pimara-8-en-7-one|pedinophyllol I

14,16-epoxy-1beta,15alpha-dihydroxy-ent-pimara-8-en-7-one|pedinophyllol I

C20H30O4 (334.2144)


   

sarsolilide B

sarsolilide B

C20H30O4 (334.2144)


   

ent-14SR,17-dihydroxykaur-15-en-19-oic acid

ent-14SR,17-dihydroxykaur-15-en-19-oic acid

C20H30O4 (334.2144)


   

7alpha,18,20-trihydroxy-ent-kaur-16-en-15-one|wikstroemioidin V

7alpha,18,20-trihydroxy-ent-kaur-16-en-15-one|wikstroemioidin V

C20H30O4 (334.2144)


   

(+)-7alpha,8beta-dihydroxydeepoxysarcophine|7alpha,8beta-dihydroxydeepoxysarcophine

(+)-7alpha,8beta-dihydroxydeepoxysarcophine|7alpha,8beta-dihydroxydeepoxysarcophine

C20H30O4 (334.2144)


   

crassumol E

crassumol E

C20H30O4 (334.2144)


   

radianspene C

radianspene C

C20H30O4 (334.2144)


   

tianchimycin A

tianchimycin A

C20H30O4 (334.2144)


   

micranthanone A

micranthanone A

C20H30O4 (334.2144)


   
   

hymatoxin E

hymatoxin E

C20H30O4 (334.2144)


   

stachysperoxide

stachysperoxide

C20H30O4 (334.2144)


   

plicatilisin B

plicatilisin B

C20H30O4 (334.2144)


   

6alpha,11beta,14beta-trihydroxy-ent-kaur-16-en-15-one|wikstroemioidin O

6alpha,11beta,14beta-trihydroxy-ent-kaur-16-en-15-one|wikstroemioidin O

C20H30O4 (334.2144)


   

3alpha,12alpha,18-trihydroxy-ent-kaur-16-en-15-one|wikstroemioidin M

3alpha,12alpha,18-trihydroxy-ent-kaur-16-en-15-one|wikstroemioidin M

C20H30O4 (334.2144)


   

6beta,9alpha-dihydroxy-15,16-epoxy-13(16),14-labdadien-7-one|isoleoheterin

6beta,9alpha-dihydroxy-15,16-epoxy-13(16),14-labdadien-7-one|isoleoheterin

C20H30O4 (334.2144)


   

15-angeloyloxy-2,3-epoxy-bisabol-10-en-1-one

15-angeloyloxy-2,3-epoxy-bisabol-10-en-1-one

C20H30O4 (334.2144)


   

athonolone|ent-7alpha,17,18-trihydroxykaur-9(11)-en-12-one

athonolone|ent-7alpha,17,18-trihydroxykaur-9(11)-en-12-one

C20H30O4 (334.2144)


   

(1R,3E,7E,11S,12R,14S)-11,12-dihydroxycembra-3,7,15(17)-trien-16,14-olide|crassocolide G

(1R,3E,7E,11S,12R,14S)-11,12-dihydroxycembra-3,7,15(17)-trien-16,14-olide|crassocolide G

C20H30O4 (334.2144)


   

Xenialactol

Xenialactol

C20H30O4 (334.2144)


   

Epoxyeleganolactone

Epoxyeleganolactone

C20H30O4 (334.2144)


   

Phomactin B

Phomactin B

C20H30O4 (334.2144)


   

tripterinin

tripterinin

C20H30O4 (334.2144)


   

1-Methyl-2-(4-methyl-3,6-dihydro-1,2-dioxin-3-ylmethyl)-3-methylene-6-(1-methylvinyl)cyclohexane 1-propionic acid

1-Methyl-2-(4-methyl-3,6-dihydro-1,2-dioxin-3-ylmethyl)-3-methylene-6-(1-methylvinyl)cyclohexane 1-propionic acid

C20H30O4 (334.2144)


   

15-hydroperoxy abietic acid|15-hydroperoxyabietic acid|7-(1-hydroperoxy-1-methyl-ethyl)-1,4a-dimethyl-1,2,3,4,4a,4b,5,6,10,10a-decahydro-phenanthrene-1-carboxylic acid

15-hydroperoxy abietic acid|15-hydroperoxyabietic acid|7-(1-hydroperoxy-1-methyl-ethyl)-1,4a-dimethyl-1,2,3,4,4a,4b,5,6,10,10a-decahydro-phenanthrene-1-carboxylic acid

C20H30O4 (334.2144)


   

11,12,16,20-Tetrahydroxy-abieta-8,11,13-triene

11,12,16,20-Tetrahydroxy-abieta-8,11,13-triene

C20H30O4 (334.2144)


   

(1S*,4S*,5S*,9R*,11S*,13E)-15,16-dihydroxy-4,5-epoxyxeniaphylla-8(19),13-dien-12-one|gibberosin G

(1S*,4S*,5S*,9R*,11S*,13E)-15,16-dihydroxy-4,5-epoxyxeniaphylla-8(19),13-dien-12-one|gibberosin G

C20H30O4 (334.2144)


   

(Z)-13,14-dihydroxy-7-oxo-caryophylla-2(12),5-dien-13-(2-methylbutyrate)

(Z)-13,14-dihydroxy-7-oxo-caryophylla-2(12),5-dien-13-(2-methylbutyrate)

C20H30O4 (334.2144)


   

cabarol isovalerate

cabarol isovalerate

C20H30O4 (334.2144)


   

amphidinolactone A

amphidinolactone A

C20H30O4 (334.2144)


   

18,19-dihydroxy-5alpha,10beta-neo-cleroda-3,13(14)-dien-16,15-butenolide|soulidiol

18,19-dihydroxy-5alpha,10beta-neo-cleroda-3,13(14)-dien-16,15-butenolide|soulidiol

C20H30O4 (334.2144)


   

13S,3beta,19-dihydroxylabda-8(17),11E-dien-16,15-olide|18beta,19-dihydroxylabda-8(17),11E-dien-16,15-olide

13S,3beta,19-dihydroxylabda-8(17),11E-dien-16,15-olide|18beta,19-dihydroxylabda-8(17),11E-dien-16,15-olide

C20H30O4 (334.2144)


   

(12E)-8,14-dioxo-8,14-secoabiet-12-en-18-oic acid|abiesadine A

(12E)-8,14-dioxo-8,14-secoabiet-12-en-18-oic acid|abiesadine A

C20H30O4 (334.2144)


   

Glaucocalyxin E

Glaucocalyxin E

C20H30O4 (334.2144)


   

18,19-dihydroxy-cis-cleroda-3,13(14)-diene-15,16-olide|Paniculadiol

18,19-dihydroxy-cis-cleroda-3,13(14)-diene-15,16-olide|Paniculadiol

C20H30O4 (334.2144)


   

3-Hydroxy-7-oxo-13楼?脥15)-cassen-16-oic acid

3-Hydroxy-7-oxo-13楼?脥15)-cassen-16-oic acid

C20H30O4 (334.2144)


   

(6betaH, 9alpha)-form-6, 9:15, 16-Diepoxy-9-hydroxy-8, 9-seco-13(16), 14-labdadien-7-one|seco-labdane|[-]-6,9:15,16-diepoxy-9alpha-hydroxy-8,9-seco-13(16),14-labdadiene-7-one

(6betaH, 9alpha)-form-6, 9:15, 16-Diepoxy-9-hydroxy-8, 9-seco-13(16), 14-labdadien-7-one|seco-labdane|[-]-6,9:15,16-diepoxy-9alpha-hydroxy-8,9-seco-13(16),14-labdadiene-7-one

C20H30O4 (334.2144)


   

Glaucocalyxin C

Glaucocalyxin C

C20H30O4 (334.2144)


   

dihydroxeniolide-A

dihydroxeniolide-A

C20H30O4 (334.2144)


   

15-hydroxy-13,14t-dehydro-14,15-dihydroichthyouleolide

15-hydroxy-13,14t-dehydro-14,15-dihydroichthyouleolide

C20H30O4 (334.2144)


   

12,15,16-trihydroxy-ent-labda-7,13-diene-15-oic acid lactone

12,15,16-trihydroxy-ent-labda-7,13-diene-15-oic acid lactone

C20H30O4 (334.2144)


   

(13S)-ent-2,7-dioxo-3-cleroden-15-oic acid|ent-2,7-Dioxo-3-cleroden-15-oic acid

(13S)-ent-2,7-dioxo-3-cleroden-15-oic acid|ent-2,7-Dioxo-3-cleroden-15-oic acid

C20H30O4 (334.2144)


   

(9S,10E,16R)-9,16-dihydroxyoctadec-10-ene-12,14-diyne-1-yl acetate

(9S,10E,16R)-9,16-dihydroxyoctadec-10-ene-12,14-diyne-1-yl acetate

C20H30O4 (334.2144)


   

15,18,19-Trihydroxy-13-16E-spatadien-5-one|5-oxo,15,18,19-trihydroxyspata-13,16-diene|5-oxo-15,18(R or S),19-trihydroxyspata-13,16(E)-diene

15,18,19-Trihydroxy-13-16E-spatadien-5-one|5-oxo,15,18,19-trihydroxyspata-13,16-diene|5-oxo-15,18(R or S),19-trihydroxyspata-13,16(E)-diene

C20H30O4 (334.2144)


   

(1R*,2E,4S*,6E,8R*,11E)-1-isopropyl-4,8-dihydroxy-4,8-dimethyl-21-oxabicyclo[10.2.2]hexadeca-2,6,11-trien-20-one|laevigatlactone E

(1R*,2E,4S*,6E,8R*,11E)-1-isopropyl-4,8-dihydroxy-4,8-dimethyl-21-oxabicyclo[10.2.2]hexadeca-2,6,11-trien-20-one|laevigatlactone E

C20H30O4 (334.2144)


   

(3beta,4beta)-3,3-C,4,4-O-tetrahydrocrinipellin A|Tetrahydrocrinipellin A

(3beta,4beta)-3,3-C,4,4-O-tetrahydrocrinipellin A|Tetrahydrocrinipellin A

C20H30O4 (334.2144)


   

neohalicholactone

neohalicholactone

C20H30O4 (334.2144)


   

8,11,13 icetexatriene-10,11,12,16-tetrol|icetexane-1

8,11,13 icetexatriene-10,11,12,16-tetrol|icetexane-1

C20H30O4 (334.2144)


   

Fumotoshidin C

Fumotoshidin C

C20H30O4 (334.2144)


   

Wightiolide

Wightiolide

C20H30O4 (334.2144)


   

(4E,10E)-3-(2-methylbutyroyloxy)-germacra-4,10(1)-diene-12,6alpha-olide

(4E,10E)-3-(2-methylbutyroyloxy)-germacra-4,10(1)-diene-12,6alpha-olide

C20H30O4 (334.2144)


   

rel-(8R,10R,20S)-8,10,20-trihydroxy-9-(10->20)-abeo-abieta-9,13-dien-12-one|sawaradienone

rel-(8R,10R,20S)-8,10,20-trihydroxy-9-(10->20)-abeo-abieta-9,13-dien-12-one|sawaradienone

C20H30O4 (334.2144)


   

2beta,16-dihydroxy-ent-labda-8(17),13-dien-15,16-olide

2beta,16-dihydroxy-ent-labda-8(17),13-dien-15,16-olide

C20H30O4 (334.2144)


   

methyl-2beta-isobutyryloxy-delta-cadinene-15-oate

methyl-2beta-isobutyryloxy-delta-cadinene-15-oate

C20H30O4 (334.2144)


   

chi-Caesalpin

chi-Caesalpin

C20H30O4 (334.2144)


   

MEGxp0_000382

MEGxp0_000382

C20H30O4 (334.2144)


   

1-farnesyl mesaconate

1-farnesyl mesaconate

C20H30O4 (334.2144)


   

3-beta,14beta,15-beta-trihydroxy-ent-kaur-16-en-12-one|pharicunin D

3-beta,14beta,15-beta-trihydroxy-ent-kaur-16-en-12-one|pharicunin D

C20H30O4 (334.2144)


   

16-hydroxy-3,4beta-epoxy-5beta,10beta-cis-17alpha,20alpha-cleroda-13(14)-en-15,16-olide|ent-3alpha,4alpha-Epoxy-16xi-hydroxy-13-cleroden-15,16-olide

16-hydroxy-3,4beta-epoxy-5beta,10beta-cis-17alpha,20alpha-cleroda-13(14)-en-15,16-olide|ent-3alpha,4alpha-Epoxy-16xi-hydroxy-13-cleroden-15,16-olide

C20H30O4 (334.2144)


   

(16S)-dihydrohyalic acid

(16S)-dihydrohyalic acid

C20H30O4 (334.2144)


   

grayanotoxin-VII

grayanotoxin-VII

C20H30O4 (334.2144)


   

Eupatoralbin

Eupatoralbin

C20H30O4 (334.2144)


   

monomethyl ester of pinifolic acid

monomethyl ester of pinifolic acid

C20H30O4 (334.2144)


   

6beta-isovaleryloxy-10beta-hydroxyfuroeremophilane

6beta-isovaleryloxy-10beta-hydroxyfuroeremophilane

C20H30O4 (334.2144)


   

18,19-dihydroxydecipi-2(4),14-dien-1-oic acid

18,19-dihydroxydecipi-2(4),14-dien-1-oic acid

C20H30O4 (334.2144)


   

wiedemannic acid

wiedemannic acid

C20H30O4 (334.2144)


   

3alpha-hydroxy-12-oxo-cleroda-4(18),13(16)-dien-15-oic acid|pentandranoic acid C

3alpha-hydroxy-12-oxo-cleroda-4(18),13(16)-dien-15-oic acid|pentandranoic acid C

C20H30O4 (334.2144)


   

(-)-3alpha,6alpha-dihydroxy-15,16-epoxy-5beta,8beta,9beta-methyl,10alpha-cleroda-13,14-dien-18-al|nepetanal

(-)-3alpha,6alpha-dihydroxy-15,16-epoxy-5beta,8beta,9beta-methyl,10alpha-cleroda-13,14-dien-18-al|nepetanal

C20H30O4 (334.2144)


   

(-)-prostaglandin E2-1,15-lactone|(3S,11aR,14R,14aR)-14-hydroxy-3-pentyl-6,7,8,11,11a,13,14,14a-octahydro-3H-cyclopenta[e]oxacyclotridecine-5,12-dione|PGE2 1,15-lactone|PGE2-1,15-lactone|Prostaglandin E2-1,15-lactone

(-)-prostaglandin E2-1,15-lactone|(3S,11aR,14R,14aR)-14-hydroxy-3-pentyl-6,7,8,11,11a,13,14,14a-octahydro-3H-cyclopenta[e]oxacyclotridecine-5,12-dione|PGE2 1,15-lactone|PGE2-1,15-lactone|Prostaglandin E2-1,15-lactone

C20H30O4 (334.2144)


   

kurubaschic acid angelate

kurubaschic acid angelate

C20H30O4 (334.2144)


   

ent-9,15alpha-dihydroxy-atis-16-en-19-saeure

ent-9,15alpha-dihydroxy-atis-16-en-19-saeure

C20H30O4 (334.2144)


   

2alpha,12beta-dihydroxy-7,15-isopimardiene-18-oic acid|wulingzhic acid B

2alpha,12beta-dihydroxy-7,15-isopimardiene-18-oic acid|wulingzhic acid B

C20H30O4 (334.2144)


   

Pachyclavuladiol

Pachyclavuladiol

C20H30O4 (334.2144)


   

2beta-angeloyloxy-8beta-hydroxypresilphiperfol-5-one|2beta-angeloyloxy-presilphiperfol-5-one

2beta-angeloyloxy-8beta-hydroxypresilphiperfol-5-one|2beta-angeloyloxy-presilphiperfol-5-one

C20H30O4 (334.2144)


   

ACMC-20mptf

ACMC-20mptf

C20H30O4 (334.2144)


   

ballotenic acid

ballotenic acid

C20H30O4 (334.2144)


A diterpenoid that is 3,4,4a,5,6,7,8,8a-octahydronaphthalene-1-carboxylic acid substituted by methyl groups at positions 5, 6 and 8a and a 2-(2-oxotetrahydrofuran-3-yl)ethyl group at position 5 (the 4aR,5S,6R,8aR stereoisomer). It is isolated from the whole plant of Ballota limbata (Syn.Otostegia limbata) and acts as a lipoxygenase inhibitor.

   

8,11,13 icetexatriene-7,10,11,16-tetrol|icetexane-3

8,11,13 icetexatriene-7,10,11,16-tetrol|icetexane-3

C20H30O4 (334.2144)


   

Bis(2-ethylbutyl) phthalate

Bis(2-ethylbutyl) phthalate

C20H30O4 (334.2144)


   

Ac-6-Hydroxy-7,9-octadecadiynoic acid

Ac-6-Hydroxy-7,9-octadecadiynoic acid

C20H30O4 (334.2144)


   

15,16-dihydroxy-7,11-dioxopimar-8(9)-ene

15,16-dihydroxy-7,11-dioxopimar-8(9)-ene

C20H30O4 (334.2144)


   

Viguieric acid

Viguieric acid

C20H30O4 (334.2144)


   

3-Ketone-3,4-Dihydroxy-13-cleroden-15,16-olide|3-oxo-4beta-hydroxy-5beta,10beta-cis-17alpha,20alpha-cleroda-13(14)-en-15,16-olide

3-Ketone-3,4-Dihydroxy-13-cleroden-15,16-olide|3-oxo-4beta-hydroxy-5beta,10beta-cis-17alpha,20alpha-cleroda-13(14)-en-15,16-olide

C20H30O4 (334.2144)


   

8,19-Dioxo-8,14-seco-chinan-14,11-olide|8,19-Dioxo-8,14-seco-chinan-14-11-olide

8,19-Dioxo-8,14-seco-chinan-14,11-olide|8,19-Dioxo-8,14-seco-chinan-14-11-olide

C20H30O4 (334.2144)


   

Arancarolon|Araucarolon

Arancarolon|Araucarolon

C20H30O4 (334.2144)


   

(1R,4aR,5R,8aR)-6-formyl-1,4a-dimethyl-5-(4-methyl-3-oxopentyl)-1,2,3,4,4a,5,8,8a-octahydronaphthalene-1-carboxylic acid|(4aR)-1c.4ar-Dimethyl-5c-(3-oxo-4-methyl-pentyl)-6-formyl-(8atH)-1.2.3.4.4a.5.8.8a-octahydro-naphthoesaeure-(1t)|13,14-dioxo-13-isopropyl-13.14-seco-podocarpen-(7)-oic acid-(15)|13,14-Dioxo-13-isopropyl-13.14-seco-podocarpen-(7)-saeure-(15)|13,14-seco-13,14-dioxoabiet-7(8)-enoic acid|13,14-seco-13,14-dioxoabiet-7-en-18-oic acid

(1R,4aR,5R,8aR)-6-formyl-1,4a-dimethyl-5-(4-methyl-3-oxopentyl)-1,2,3,4,4a,5,8,8a-octahydronaphthalene-1-carboxylic acid|(4aR)-1c.4ar-Dimethyl-5c-(3-oxo-4-methyl-pentyl)-6-formyl-(8atH)-1.2.3.4.4a.5.8.8a-octahydro-naphthoesaeure-(1t)|13,14-dioxo-13-isopropyl-13.14-seco-podocarpen-(7)-oic acid-(15)|13,14-Dioxo-13-isopropyl-13.14-seco-podocarpen-(7)-saeure-(15)|13,14-seco-13,14-dioxoabiet-7(8)-enoic acid|13,14-seco-13,14-dioxoabiet-7-en-18-oic acid

C20H30O4 (334.2144)


   

8beta,17-epoxy-11,15-epoxy-15-hydroxy-12-labden-16-al

8beta,17-epoxy-11,15-epoxy-15-hydroxy-12-labden-16-al

C20H30O4 (334.2144)


   

8alpha-Angeloyloxy-9alpha-hydroxy-2-oxo-10beta-H-eremophil-11(12)-en

8alpha-Angeloyloxy-9alpha-hydroxy-2-oxo-10beta-H-eremophil-11(12)-en

C20H30O4 (334.2144)


   

5(S)-HpEPE

5S-hydroperoxy-6E,8Z,11Z,14Z,17Z-eicosapentaenoic acid

C20H30O4 (334.2144)


   

15(S)- HPEPE

15(S)- HPEPE

C20H30O4 (334.2144)


   

ACMC-20m4zl

ACMC-20m4zl

C20H30O4 (334.2144)


   

20-carboxy Arachidonic Acid

5Z,8Z,11Z,14Z-Eicosatetraenedioic acid

C20H30O4 (334.2144)


   

14,15-dehydro-LTB4

5S,12R-dihydroxy-6Z,8E,10E-eicosatriene-14-ynoic acid

C20H30O4 (334.2144)


   
   

MLS000574943-01!

MLS000574943-01!

C20H30O4 (334.2144)


   

C20H30O4_1-Phenanthrenecarboxylic acid, 1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydro-7-hydroxy-1,4a-dimethyl-7-(1-methylethyl)-9-oxo

NCGC00380522-01_C20H30O4_1-Phenanthrenecarboxylic acid, 1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydro-7-hydroxy-1,4a-dimethyl-7-(1-methylethyl)-9-oxo-

C20H30O4 (334.2144)


   

C20H30O4_1,10a-Dihydroxy-4,4,7,11b-tetramethyl-2,3,4,4a,5,6,6a,7,10a,11,11a,11b-dodecahydrophenanthro[3,2-b]furan-9(1H)-one

NCGC00381378-01_C20H30O4_1,10a-Dihydroxy-4,4,7,11b-tetramethyl-2,3,4,4a,5,6,6a,7,10a,11,11a,11b-dodecahydrophenanthro[3,2-b]furan-9(1H)-one

C20H30O4 (334.2144)


   

C20H30O4_6,18,19-Trihydroxytrachyloban-2-one

NCGC00168836-03_C20H30O4_6,18,19-Trihydroxytrachyloban-2-one

C20H30O4 (334.2144)


   

C20H30O4_17-Hydroxy-15,16-epoxykauran-18-oic acid

NCGC00347612-02_C20H30O4_17-Hydroxy-15,16-epoxykauran-18-oic acid

C20H30O4 (334.2144)


   

C20H30O4_2-Hydroxy-4,5,8a-trimethyl-1-oxo-4-vinyloctahydro-1H-spiro[cyclopentane-1,2-naphthalene]-5-carboxylic acid

NCGC00380721-01_C20H30O4_2-Hydroxy-4,5,8a-trimethyl-1-oxo-4-vinyloctahydro-1H-spiro[cyclopentane-1,2-naphthalene]-5-carboxylic acid

C20H30O4 (334.2144)


   

Eicosanoids_PGJ2_C20H30O4

Eicosanoids_PGJ2_C20H30O4

C20H30O4 (334.2144)


   

C20H30O4_(5beta,8alpha,10alpha,16xi)-16,17-Dihydroxykaur-9(11)-en-18-oic acid

NCGC00380240-01_C20H30O4_(5beta,8alpha,10alpha,16xi)-16,17-Dihydroxykaur-9(11)-en-18-oic acid

C20H30O4 (334.2144)


   

C20H30O4_3-{2-[(1R,4aS,5R,8aS)-6-Hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydro-1-naphthalenyl]ethyl}-2(5H)-furanone

NCGC00168865-02_C20H30O4_3-{2-[(1R,4aS,5R,8aS)-6-Hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydro-1-naphthalenyl]ethyl}-2(5H)-furanone

C20H30O4 (334.2144)


   

C20H30O4_Spiro[naphthalene-1(2H),2-oxirane]-2,3-diol, 5-[2-(3-furanyl)ethyl]octahydro-5,6,8a-trimethyl-, (1R,2S,3R,5S,6R,8aR)

NCGC00380338-01_C20H30O4_Spiro[naphthalene-1(2H),2-oxirane]-2,3-diol, 5-[2-(3-furanyl)ethyl]octahydro-5,6,8a-trimethyl-, (1R,2S,3R,5S,6R,8aR)-

C20H30O4 (334.2144)


   

C20H30O4_Kaurane-17,18-dioic acid

NCGC00384568-01_C20H30O4_Kaurane-17,18-dioic acid

C20H30O4 (334.2144)


   

Prostaglandin B2

15S-hydroxy-9-oxo-5Z,8(12),13E-prostatrienoic acid

C20H30O4 (334.2144)


   

4-[2-[(1R,4aS,5R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethyl]-2H-furan-5-one

4-[2-[(1R,4aS,5R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethyl]-2H-furan-5-one

C20H30O4 (334.2144)


   

5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5,14-dicarboxylic acid

5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5,14-dicarboxylic acid

C20H30O4 (334.2144)


   

7-hydroxy-1,4a-dimethyl-9-oxo-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid

7-hydroxy-1,4a-dimethyl-9-oxo-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid

C20H30O4 (334.2144)


   

14-(hydroxymethyl)-5,9-dimethyl-15-oxapentacyclo[11.3.1.0¹,¹⁰.0⁴,⁹.0¹⁴,¹⁶]heptadecane-5-carboxylic acid

14-(hydroxymethyl)-5,9-dimethyl-15-oxapentacyclo[11.3.1.0¹,¹⁰.0⁴,⁹.0¹⁴,¹⁶]heptadecane-5-carboxylic acid

C20H30O4 (334.2144)


   

4-ethenyl-2-hydroxy-1,4,4a-trimethyl-5-oxospiro[2,3,4,7,8,8a-hexahydronaphthalene-6,1-cyclopentane]-1-carboxylic acid

4-ethenyl-2-hydroxy-1,4,4a-trimethyl-5-oxospiro[2,3,4,7,8,8a-hexahydronaphthalene-6,1-cyclopentane]-1-carboxylic acid

C20H30O4 (334.2144)


   

1,10a-dihydroxy-4,4,7,11b-tetramethyl-1,2,3,4a,5,6,6a,7,11,11a-decahydronaphtho[2,1-f][1]benzofuran-9-one

1,10a-dihydroxy-4,4,7,11b-tetramethyl-1,2,3,4a,5,6,6a,7,11,11a-decahydronaphtho[2,1-f][1]benzofuran-9-one

C20H30O4 (334.2144)


   

Kalkipyrone B

Kalkipyrone B

C20H30O4 (334.2144)


   

Euphoractine R from S.guyanensis

Euphoractine R from S.guyanensis

C20H30O4 (334.2144)


   

Jatrointelone M from S.guyanensis

Jatrointelone M from S.guyanensis

C20H30O4 (334.2144)


   

15d-PGJ2-[d4]

15d-PGJ2-[d4]

C20H30O4 (334.2144)


CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0219.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0219.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0219.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000149.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000149.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000149.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000149.mzML; PROCESSING averaging of repeated ion fragments at 40.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000149.mzML; PROCESSING averaging of repeated ion fragments at 30.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000149.mzML; PROCESSING averaging of repeated ion fragments at 20.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ]

   

PGB2-[d4]

PGB2-[d4]

C20H30O4 (334.2144)


CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0220.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0220.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0220.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000151.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000151.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000151.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000151.mzML; PROCESSING averaging of repeated ion fragments at 40.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000151.mzML; PROCESSING averaging of repeated ion fragments at 30.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000151.mzML; PROCESSING averaging of repeated ion fragments at 20.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ]

   

Lapidin

Lapidin

C20H30O4 (334.2144)


Origin: Plant; SubCategory_DNP: Sesquiterpenoids

   

leukotriene b5

5S,12S-dihydroxy-6Z,8E,14Z,17Z-eicosapentanenoic acid

C20H30O4 (334.2144)


A leukotriene composed of (6Z,8E,10E,14Z,17Z)-icosapentaenoic acid carrying (5S)- and (12R)-hydroxy substituents.

   

1,10a-dihydroxy-4,4,7,11b-tetramethyl-1,2,3,4a,5,6,6a,7,11,11a-decahydronaphtho[2,1-f][1]benzofuran-9-one_major

1,10a-dihydroxy-4,4,7,11b-tetramethyl-1,2,3,4a,5,6,6a,7,11,11a-decahydronaphtho[2,1-f][1]benzofuran-9-one_major

C20H30O4 (334.2144)


   

14-(hydroxymethyl)-5,9-dimethyl-15-oxapentacyclo[11.3.1.0¹,¹⁰.0⁴,⁹.0¹⁴,¹⁶]heptadecane-5-carboxylic acid_major

14-(hydroxymethyl)-5,9-dimethyl-15-oxapentacyclo[11.3.1.0¹,¹⁰.0⁴,⁹.0¹⁴,¹⁶]heptadecane-5-carboxylic acid_major

C20H30O4 (334.2144)


   

4-[2-[(1R,4aS,5R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethyl]-2H-furan-5-one_major

4-[2-[(1R,4aS,5R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethyl]-2H-furan-5-one_major

C20H30O4 (334.2144)


   

(E)-5-[(1S,8aS)-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-(hydroxymethyl)-2-oxopent-3-enoic acid_81.6\\%

(E)-5-[(1S,8aS)-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-(hydroxymethyl)-2-oxopent-3-enoic acid_81.6\\%

C20H30O4 (334.2144)


   

(E)-5-[(1S,8aS)-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-(hydroxymethyl)-2-oxopent-3-enoic acid_major

(E)-5-[(1S,8aS)-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-(hydroxymethyl)-2-oxopent-3-enoic acid_major

C20H30O4 (334.2144)


   

5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5,14-dicarboxylic acid_major

5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5,14-dicarboxylic acid_major

C20H30O4 (334.2144)


   

5,9-dimethyltetracyclo[11.2.1.0¹,¹?.0?,?]hexadecane-5,14-dicarboxylic acid

5,9-dimethyltetracyclo[11.2.1.0¹,¹?.0?,?]hexadecane-5,14-dicarboxylic acid

C20H30O4 (334.2144)


   

15-deoxy-δ-12,14-PGD2

9S-hydroxy-11-oxo-5Z,12E,14E-prostatrienoic acid

C20H30O4 (334.2144)


   

15R-PGA2

9oxo-15R-hydroxy-5Z,10Z,13E-prostatrienoic acid

C20H30O4 (334.2144)


   

5-trans-PGA2

9oxo-15S-hydroxy-5E,10Z,13E-prostatrienoic acid

C20H30O4 (334.2144)


   

12(S)-HpEPE

12S-hydroperoxy-5Z,8Z,10E,14Z,17Z-eicosapentaenoic acid

C20H30O4 (334.2144)


A 12-HPEPE in which the hydroperoxy group at positions 12 has S-configuration.

   

15(S)-HpEPE

15S-hydroperoxy-5Z,8Z,11Z,13E,17Z-eicosapentaenoic acid

C20H30O4 (334.2144)


   

5,12-Dihydroxy-6,8,10,14,17-eicosapentaenoic acid

5,12-Dihydroxy-6,8,10,14,17-eicosapentaenoic acid

C20H30O4 (334.2144)


   

DHK-PGA2

(5Z)-7-[(1R,5S)-2-oxo-5-(3-oxooctyl)cyclopent-3-en-1-yl]hept-5-enoic acid

C20H30O4 (334.2144)


   

bicyclo-PGE2

(Z)-7-[(1R,3aS,7aS)-4-butyl-2,5-dioxo-3,3a,4,6,7,7a-hexahydro-1H-inden-1-yl]hept-5-enoic acid

C20H30O4 (334.2144)


   

8-iso Prostaglandin A2

9-oxo-15S-hydroxy-(8β)-prosta-5Z,10,13E-trien-1-oic acid

C20H30O4 (334.2144)


   

PGF3alpha-1,15-lactone

9S,11R-dihydroxy-5Z,13E,17Z-prostatrienoic acid-1,15S-lactone

C20H30O4 (334.2144)


   

PGE2 1,15-lactone

9-oxo-11R-hydroxy-5Z,13E-prostadienoic acid-1,15S-lactone

C20H30O4 (334.2144)


   

(-)-Cassaic acid

(-)-Cassaic acid

C20H30O4 (334.2144)


   

(-)-Leucothol C

(-)-Leucothol C

C20H30O4 (334.2144)


   

7beta-Hydroxy-lathyrol

7beta-Hydroxy-lathyrol

C20H30O4 (334.2144)


   

(-)-8,16-Dihydroxy-19-serrulatanoic acid

(-)-8,16-Dihydroxy-19-serrulatanoic acid

C20H30O4 (334.2144)


   

5Z,8Z,11Z,14Z-Eicosatetraenedioic acid

5Z,8Z,11Z,14Z-Eicosatetraenedioic acid

C20H30O4 (334.2144)


   

18S-RvE2

5S,18S-dihydroxy-6E,8Z,11Z,14Z,16E-eicosapentaenoic acid

C20H30O4 (334.2144)


   

18R-HpEPE

18R-hydroperoxy-5Z,8Z,11Z,14Z,16E-eicosapentaenoic acid

C20H30O4 (334.2144)


   

ent-8-J2-IsoP

8R-hydroxy-14-oxo-5Z,9E,12-prostatrienoic acid-cyclo[11S,15R]

C20H30O4 (334.2144)


   

8-J2-IsoP

8S-hydroxy-14-oxo-5Z,9E,12-prostatrienoic acid-cyclo[11R,15S]

C20H30O4 (334.2144)


   

8-epi-8-J2-IsoP

8R-hydroxy-14-oxo-5Z,9E,12-prostatrienoic acid-cyclo[11R,15S]

C20H30O4 (334.2144)


   

ent-8-epi-8-J2-IsoP

8S-hydroxy-14-oxo-5Z,9E,12-prostatrienoic acid-cyclo[11S,15R]

C20H30O4 (334.2144)


   

ent-5-J2-IsoP

5R-hydroxy-11-oxo-6E,14Z,12-prostatrienoic acid-cyclo[8S,12R]

C20H30O4 (334.2144)


   

5-J2-IsoP

5S-hydroxy-11-oxo-6E,14Z,12-prostatrienoic acid-cyclo[8R,12S]

C20H30O4 (334.2144)


   

5-epi-5-J2-IsoP

5R-hydroxy-11-oxo-6E,14Z,12-prostatrienoic acid-cyclo[8R,12S]

C20H30O4 (334.2144)


   

ent-5-epi-5-J2-IsoP

5S-hydroxy-11-oxo-6E,14Z,12-prostatrienoic acid-cyclo[8S,12R]

C20H30O4 (334.2144)


   

ent-12-J2-IsoP

12R-hydroxy-8-oxo-6,10E,14Z-prostatrienoic acid-cyclo[5R,9R]

C20H30O4 (334.2144)


   

12-J2-IsoP

12S-hydroxy-8-oxo-6,10E,14Z-prostatrienoic acid-cyclo[5S,9S]

C20H30O4 (334.2144)


   

12-epi-12-J2-IsoP

12R-hydroxy-8-oxo-6,10E,14Z-prostatrienoic acid-cyclo[5S,9S]

C20H30O4 (334.2144)


   

ent-12-epi-12-J2-IsoP

12S-hydroxy-8-oxo-6,10E,14Z-prostatrienoic acid-cyclo[5R,9R]

C20H30O4 (334.2144)


   

ent-15-J2-IsoP

15R-hydroxy-11-oxo-5Z,9,13E-prostatrienoic acid-cyclo[8R,12R]

C20H30O4 (334.2144)


   

15-J2-IsoP

15S-hydroxy-11-oxo-5Z,9,13E-prostatrienoic acid-cyclo[8S,12S]

C20H30O4 (334.2144)


   

15-epi-15-J2-IsoP

15R-hydroxy-11-oxo-5Z,9,13E-prostatrienoic acid-cyclo[8S,12S]

C20H30O4 (334.2144)


   

ent-15-epi-15-J2-IsoP

15S-hydroxy-11-oxo-5Z,9,13E-prostatrienoic acid-cyclo[8R,12R]

C20H30O4 (334.2144)


   

8-epi-15-J2-IsoP

11-oxo-15S-hydroxy-5Z,9,13E-prostatrienoic acid-cyclo[8S,12S]

C20H30O4 (334.2144)


   

8,15-diepi-15-J2t-IsoP

11-oxo-15R-hydroxy-5Z,9,13E-prostatrienoic acid-cyclo[8S,12R]

C20H30O4 (334.2144)


   

8,15-diepi-15-J2c-IsoP

11-oxo-15R-hydroxy-5Z,9,13E-prostatrienoic acid-cyclo[8R,12S]

C20H30O4 (334.2144)


   

8-epi-15-J2t-IsoP

11-oxo-15S-hydroxy-5Z,9,13E-prostatrienoic acid-cyclo[8S,12R]

C20H30O4 (334.2144)


   

15-epi-15-A2t-IsoP

9-oxo-15R-hydroxy-5Z,10,13E-prostatrienoic acid-cyclo[8S,12S]

C20H30O4 (334.2144)


   

15-A2c-IsoP

9-oxo-15S-hydroxy-5Z,10,13E-prostatrienoic acid-cyclo[8R,12R]

C20H30O4 (334.2144)


   

15-epi-15-A2c-IsoP

9-oxo-15R-hydroxy-5Z,10,13E-prostatrienoic acid-cyclo[8R,12R]

C20H30O4 (334.2144)


   

15-A2t-IsoP

9-oxo-15S-hydroxy-5Z,10,13E-prostatrienoic acid-cyclo[8S,12S]

C20H30O4 (334.2144)


   

8-epi-15-A2c-IsoP

9-oxo-15S-hydroxy-5Z,10,13E-prostatrienoic acid-cyclo[8S,12R]

C20H30O4 (334.2144)


   

8,15-diepi-15-A2c-IsoP

9-oxo-15R-hydroxy-5Z,10,13E-prostatrienoic acid-cyclo[8S,12R]

C20H30O4 (334.2144)


   
   

Vaginatin

(1R,3aR,4R,8aS)-8a-hydroxy-3a,6-dimethyl-3-oxo-1-(propan-2-yl)-1,2,3,3a,4,7,8,8a-octahydroazulen-4-yl (2Z)-2-methylbut-2-enoate

C20H30O4 (334.2144)


   

8alpha-8-Hydroxy-12-oxo-13-abieten-18-oic acid

8a-hydroxy-1,4a-dimethyl-6-oxo-7-(propan-2-yl)-1,2,3,4,4a,4b,5,6,8a,9,10,10a-dodecahydrophenanthrene-1-carboxylic acid

C20H30O4 (334.2144)


   

(ent-16betaOH)-16,17-Dihydroxy-9(11)-kauren-19-oic acid

14-hydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0^{1,10}.0^{4,9}]hexadec-10-ene-5-carboxylic acid

C20H30O4 (334.2144)


   

Dehydropinifolic acid

5-[(3Z)-4-carboxy-3-methylbut-3-en-1-yl]-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid

C20H30O4 (334.2144)


   

phytocassane B

2-ethenyl-5,6,7-trihydroxy-1,4b,8,8-tetramethyl-1,4,4a,4b,5,6,7,8,8a,9,10,10a-dodecahydrophenanthren-4-one

C20H30O4 (334.2144)


   

18S-RvE3

17R,18S-dihydroxy-5Z,8Z,11Z,13E,15E-eicosapentaenoic acid

C20H30O4 (334.2144)


   

18R-RvE3

17R,18R-dihydroxy-5Z,8Z,11Z,13E,15E-eicosapentaenoic acid

C20H30O4 (334.2144)


   

11,18-di-HEPE

11,18-dihydroxy-5Z,8Z,12E,14Z,16E-eicosapentaenoic acid

C20H30O4 (334.2144)


   

12,18-di-HEPE

12,18-dihydroxy-5Z,8Z,10E,14Z,16E-eicosapentaenoic acid

C20H30O4 (334.2144)


   

8,18-di-HEPE

8,18-dihydroxy-5Z,9E,11Z,14Z,16E-eicosapentaenoic acid

C20H30O4 (334.2144)


   

14-Deoxyandrographolide

3-(2-((1R,4aS,5R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydronaphthalen-1-yl)ethyl)furan-2(5H)-one

C20H30O4 (334.2144)


   

13-Hydroxy-7-oxoabiet-8(14)-en-18-oic acid

13-Hydroxy-7-oxoabiet-8(14)-en-18-oic acid

C20H30O4 (334.2144)


   

FA 20:5;O2

4-((1R,5S)-5-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)butanoic acid

C20H30O4 (334.2144)


An oxylipin that is the (5S,6S)-epoxy-(15S)-hydroxy derivative of 7E,9E,11Z,13E-icosa-7,9,11,13-tetraenoic acid. D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000970 - Antineoplastic Agents

   

Prostaglandin J2

11-oxo-15S-hydroxy-5Z,9,13E-prostatrienoic acid-cyclo[8S,12R]

C20H30O4 (334.2144)


A member of the class of prostaglandins J that consists of prosta-5,9,13-trien-1-oic acid substituted by an oxo group at position 11 and a hydroxy group at position 15 (the 5Z,13E,15S stereoisomer). D000970 - Antineoplastic Agents

   

PROSTAGLANDIN A2

9-oxo-15S-hydroxy-5Z,10Z,13E-prostatrienoic acid

C20H30O4 (334.2144)


   

Prostaglandin C2

9-oxo-15S-hydroxy-5Z,11Z,13E-prostatrienoic acid

C20H30O4 (334.2144)


A member of the class of prostaglandins C that is prosta-5,11,13-trien-1-oic acid carrying oxo and hydroxy substituents at positions 9 and 15 respectively (the 5Z,13E,15S-stereoisomer).

   

5E-PGB2

15S-hydroxy-9-oxo-5E,8(12),13E-prostatrienoic acid

C20H30O4 (334.2144)


   

7,8-HepETE

8,9-epoxy-7-hydroxy-5Z,11Z,14Z,17Z-eicosatetraenoic acid

C20H30O4 (334.2144)


   

5S-HpEPE

5S-hydroperoxy-6E,8Z,11Z,14Z,17Z-eicosapentaenoic acid

C20H30O4 (334.2144)


   

12S-HpEPE

12S-hydroperoxy-5Z,8Z,10E,14Z,17Z-eicosapentaenoic acid

C20H30O4 (334.2144)


   

15S-HpEPE

15S-hydroperoxy-5Z,8Z,11Z,13E,17Z-eicosapentaenoic acid

C20H30O4 (334.2144)


   

14-HpEPE

14-hydroperoxy-5Z,8Z,11Z,15E,17Z-eicosapentaenoic acid

C20H30O4 (334.2144)


   

9S-HpEPE

9S-hydroperoxy-5Z,7E,11Z,14Z,17Z-eicosapentaenoic acid

C20H30O4 (334.2144)


   

5R-HpEPE

5R-hydroperoxy-6E,8Z,11Z,14Z,17Z-eicosapentaenoic acid

C20H30O4 (334.2144)


   

12-A2-IsoP

4-((1R,2R)-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)butanoic acid

C20H30O4 (334.2144)


   

5-A2-IsoP

(S,E)-5-hydroxy-7-((1R,2R)-2-((Z)-oct-2-en-1-yl)-5-oxocyclopent-3-en-1-yl)hept-6-enoic acid

C20H30O4 (334.2144)


   

8-A2-IsoP

(S,5Z,9E)-8-hydroxy-10-((1R,5R)-2-oxo-5-pentylcyclopent-3-en-1-yl)deca-5,9-dienoic acid

C20H30O4 (334.2144)


   

Resolvin E4

5S,15S-dihydroxy-6E,8Z,11Z,13E,17Z-eicosapentaenoic acid

C20H30O4 (334.2144)


   

Cymatherol C

9-[(1R,2S,3S,5S)-3-[(1S,2R)-2-[(1R)-1-Hydroxypropyl]cyclopropyl]-6-oxabicyclo[3.1.0]hexan-2-yl]nona-5Z,8Z-dienoic acid

C20H30O4 (334.2144)


   

Ectocarpin C

(5Z,8Z,11Z)-12-{(1R,2S,3S,5S)-3-[(1E)-1-hydroxypropyl]-6-oxabicyclo[3.1.0]hex-2-yl}-5,8,11-dodecatrienoic acid

C20H30O4 (334.2144)


   

bis(2-ethylbutyl) benzene-1,2-dicarboxylate

bis(2-ethylbutyl) benzene-1,2-dicarboxylate

C20H30O4 (334.2144)


   

2,5-dihexoxyterephthalaldehyde

2,5-dihexoxyterephthalaldehyde

C20H30O4 (334.2144)


   

9α,13α-Epidioxyabiet-8(14)-en-18-oic acid

9α,13α-Epidioxyabiet-8(14)-en-18-oic acid

C20H30O4 (334.2144)


   

ent-11,16-Epoxy-15-hydroxykauran-19-oic acid

ent-11,16-Epoxy-15-hydroxykauran-19-oic acid

C20H30O4 (334.2144)


   

ent-9-Hydroxy-15-oxo-19-kauraic acid

ent-9-Hydroxy-15-oxo-19-kauraic acid

C20H30O4 (334.2144)


   

Staflex BOP

Staflex BOP

C20H30O4 (334.2144)


   

butyl 2-ethylhexyl phthalate

butyl 2-ethylhexyl phthalate

C20H30O4 (334.2144)


   

5-(6-HYDROXY-2,5,7,8-TETRAMETHYL-CHROMAN-2-YL)-2-METHYL-PENTANOIC ACID METHYL ESTER

5-(6-HYDROXY-2,5,7,8-TETRAMETHYL-CHROMAN-2-YL)-2-METHYL-PENTANOIC ACID METHYL ESTER

C20H30O4 (334.2144)


   

(13α)-11,15-Dihydroxykaur-16-en-18-oic acid

(13α)-11,15-Dihydroxykaur-16-en-18-oic acid

C20H30O4 (334.2144)


   

15-Oxoprostaglandin B1

15-Oxoprostaglandin B1

C20H30O4 (334.2144)


   

8-iso-prostaglandin A2

8-iso-prostaglandin A2

C20H30O4 (334.2144)


   

5-Oxo-15-hete

5-Oxo-15-hete

C20H30O4 (334.2144)


   

2-Hydroxy-4,5,8a-trimethyl-1-oxo-4-vinyloctahydro-1H-spiro[cyclopentane-1,2-naphthalene]-5-carboxylic acid

2-Hydroxy-4,5,8a-trimethyl-1-oxo-4-vinyloctahydro-1H-spiro[cyclopentane-1,2-naphthalene]-5-carboxylic acid

C20H30O4 (334.2144)


   

Prostaglandin A2-d4

Prostaglandin A2-d4

C20H30O4 (334.2144)


   

15-dehydroprostaglandin A1

15-dehydroprostaglandin A1

C20H30O4 (334.2144)


A member of the class of prostaglandins A obtained by oxidation of the 15-hydroxy group of prostaglandin A1 to the corresponding ketone.

   

(6E,8Z,11Z,14Z,17Z)-5-Hydroperoxy-6,8,11,14,17-eicosapentaenoic acid

(6E,8Z,11Z,14Z,17Z)-5-Hydroperoxy-6,8,11,14,17-eicosapentaenoic acid

C20H30O4 (334.2144)


   

FR-0229

1,2-Benzenedicarboxylic acid, C6-12-alkyl esters

C20H30O4 (334.2144)


   

15-deoxy-PGD2

(5Z)-7-[(1R,2E,5S)-5-hydroxy-2-[(2E)-oct-2-en-1-ylidene]-3-oxocyclopentyl]hept-5-enoic acid

C20H30O4 (334.2144)


15-deoxy-PGD2 is classified as a member of the Prostaglandins and related compounds. Prostaglandins and related compounds are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid. 15-deoxy-PGD2 is considered to be practically insoluble (in water) and acidic. 15-deoxy-PGD2 is an eicosanoid lipid molecule

   

(E)-7-[2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopenten-1-yl]hept-5-enoic acid

(E)-7-[2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopenten-1-yl]hept-5-enoic acid

C20H30O4 (334.2144)


   

(1beta,2beta,3beta,14alpha)-1,2,3-Trihydroxy-14-methyl-13-vinylpodocarp-12-en-11-one

(1beta,2beta,3beta,14alpha)-1,2,3-Trihydroxy-14-methyl-13-vinylpodocarp-12-en-11-one

C20H30O4 (334.2144)


   

4-[(2R,3S)-3-[(1E,3E,5Z,7E,9S)-9-hydroxytetradeca-1,3,5,7-tetraenyl]oxiran-2-yl]butanoic acid

4-[(2R,3S)-3-[(1E,3E,5Z,7E,9S)-9-hydroxytetradeca-1,3,5,7-tetraenyl]oxiran-2-yl]butanoic acid

C20H30O4 (334.2144)


   

4-[(2R,3S)-3-[(1E,3E,5Z,7E,9R)-9-hydroxytetradeca-1,3,5,7-tetraenyl]oxiran-2-yl]butanoic acid

4-[(2R,3S)-3-[(1E,3E,5Z,7E,9R)-9-hydroxytetradeca-1,3,5,7-tetraenyl]oxiran-2-yl]butanoic acid

C20H30O4 (334.2144)


   

(1R,2R,4S,5R,9S,10S,15S)-2-hydroxy-5,9,14-trimethyl-13-oxapentacyclo[12.2.1.01,10.04,9.012,15]heptadecane-5-carboxylic acid

(1R,2R,4S,5R,9S,10S,15S)-2-hydroxy-5,9,14-trimethyl-13-oxapentacyclo[12.2.1.01,10.04,9.012,15]heptadecane-5-carboxylic acid

C20H30O4 (334.2144)


   

(1R,2S,4S,5R,9S,10S,15S)-2-hydroxy-5,9,14-trimethyl-13-oxapentacyclo[12.2.1.01,10.04,9.012,15]heptadecane-5-carboxylic acid

(1R,2S,4S,5R,9S,10S,15S)-2-hydroxy-5,9,14-trimethyl-13-oxapentacyclo[12.2.1.01,10.04,9.012,15]heptadecane-5-carboxylic acid

C20H30O4 (334.2144)


   

5-oxo-12-HETE

5-oxo-12-HETE

C20H30O4 (334.2144)


   

Agathenic acid

Agathenic acid

C20H30O4 (334.2144)


   

5-Heptenoic acid, 7-(4-butyloctahydro-2,5-dioxo-1H-inden-1-yl)-

5-Heptenoic acid, 7-(4-butyloctahydro-2,5-dioxo-1H-inden-1-yl)-

C20H30O4 (334.2144)